SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Alpha and beta proteins (a+b) (23004)
(-)
Fold: Protein kinase-like (PK-like) (2589)
(-)
Superfamily: Protein kinase-like (PK-like) (2589)
(-)
Family: Protein kinases, catalytic subunit (1977)
(-)
Protein domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 (25)
(-)
Human (Homo sapiens) [TaxId: 9606] (25)
1H1WA:HIGH RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PDK1 CATALYTIC DOMAIN
1OKYA:STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
1OKZA:STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH UCN-01
1UU3A:STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH LY333531
1UU7A:STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-2
1UU8A:STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-1
1UU9A:STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-3
1UVRA:STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-8
1Z5MA:CRYSTAL STRUCTURE OF N1-[3-[[5-BROMO-2-[[3-[(1-PYRROLIDINYLCARBONYL) AMINO]PHENYL]AMINO]-4-PYRIMIDINYL]AMINO]PROPYL]-2,2-DIMETHYLPROPANEDIAMIDE COMPLEXED WITH HUMAN PDK1
2PE0A:CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-HYDROXY-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-1,3-DIHYDRO-INDOL-2-ONE COMPLEX
2PE1A:CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) {2-OXO-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-2,3-DIHYDRO-1H-INDOL-5-YL}-UREA {BX-517} COMPLEX
2PE2A:CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 3-{5-[2-OXO-5-UREIDO-1,2-DIHYDRO-INDOL-(3Z)-YLIDENEMETHYL]-1H-PYRROL-3-YL}-N-(2-PIPERIDIN-1-YL-ETHYL)-BENZAMIDE COMPLEX
2R7BA:CRYSTAL STRUCTURE OF THE PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK-1)CATALYTIC DOMAIN BOUND TO A DIBENZONAPHTHYRIDINE INHIBITOR
3IONA:PDK1 IN COMPLEX WITH COMPOUND 8H
3IOPA:PDK-1 IN COMPLEX WITH THE INHIBITOR COMPOUND-8I
3NAYA:; B:PDK1 IN COMPLEX WITH INHIBITOR MP6
3NUNA:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH LEAD COMPOUND
3NUSA:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH FRAGMENT8
3NUUA:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH FRAGMENT11
3NUYA:PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK1) WITH FRAGMENT17
3QC4A:; B:76-359PDK1 IN COMPLEX WITH DFG-OUT INHIBITOR XXX
3RCJA:RAPID PREPARATION OF TRIAZOLYL SUBSTITUTED NH-HETEROCYCLIC KINASE INHIBITORS VIA ONE-POT SONOGASHIRA COUPLING TMS-DEPROTECTION CUAAC SEQUENCE
3RWPA:DISCOVERY OF A NOVEL, POTENT AND SELECTIVE INHIBITOR OF 3-PHOSPHOINOSITIDE DEPENDENT KINASE (PDK1)
3RWQA:DISCOVERY OF A NOVEL, POTENT AND SELECTIVE INHIBITOR OF 3-PHOSPHOINOSITIDE DEPENDENT KINASE (PDK1)
3SC1A:NOVEL ISOQUINOLONE PDK1 INHIBITORS DISCOVERED THROUGH FRAGMENT-BASED LEAD DISCOVERY
(-)
Protein domain: Abelsone tyrosine kinase (abl) (12)
(-)
Human (Homo sapiens) [TaxId: 9606] (5)
2FO0A:240-530ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORMS OF THE C-ABL TYROSINE KINASE
2HYYA:; B:; C:; D:HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571, GLIVEC)
2HZ0A:; B:ABL KINASE DOMAIN IN COMPLEX WITH NVP-AEG082
2HZ4A:; B:; C:ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROSTAUROSPORINE
2HZIA:; B:ABL KINASE DOMAIN IN COMPLEX WITH PD180970
(-)
Mouse (Mus musculus) [TaxId: 10090] (7)
1FPUA:; B:CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1IEPA:; B:CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
1M52A:; B:CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH PD173955
1OPJA:; B:STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
1OPKA:241-531STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
1OPLA:241-531; B:252-518STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
2HZNA:ABL KINASE DOMAIN IN COMPLEX WITH NVP-AFG210
(-)
Protein domain: Activated CDC42 kinase 1, ACK1 (8)
(-)
Human (Homo sapiens) [TaxId: 9606] (8)
1U46A:; B:CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1
1U4DA:; B:STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE
1U54A:; B:CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP
3EQPA:; B:CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95
3EQRA:; B:CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T74
4EWHA:; B:CO-CRYSTAL STRUCTURE OF ACK1 WITH INHIBITOR
4HZRA:; B:CRYSTAL STRUCTURE OF ACK1 KINASE DOMAIN
4ID7A:ACK1 KINASE IN COMPLEX WITH THE INHIBITOR CIS-3-[8-AMINO-1-(4-PHENOXYPHENYL)IMIDAZO[1,5-A]PYRAZIN-3-YL]CYCLOBUTANOL
(-)
Protein domain: Aurora-related kinase 1 (aurora-2) (39)
(-)
Human (Homo sapiens) [TaxId: 9606] (39)
1MQ4A:CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE
1MUOA:CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE
1OL5A:STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND BOUND TO TPX2 1-43
1OL6A:STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A
1OL7A:STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287, THR288
2WQEA:STRUCTURE OF S155R AURORA-A SOMATIC MUTANT
3COHA:; B:CRYSTAL STRUCTURE OF AURORA-A IN COMPLEX WITH A PENTACYCLIC INHIBITOR
3E5AA:CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH VX-680 AND TPX2
3EFWA:; B:STRUCTURE OF AURORAA WITH PYRIDYL-PYRIMIDINE UREA INHIBITOR
3H0YA:AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
3H0ZA:; B:; C:AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
3H10A:; B:; D:AURORA A INHIBITOR COMPLEX
3MYGA:AURORA A KINASE COMPLEXED WITH SCH 1473759
3NRMA:IMIDAZO[1,2-A]PYRAZINE-BASED AURORA KINASE INHIBITORS
3O50A:; B:CRYSTAL STRUCTURE OF BENZAMIDE 9 BOUND TO AURORAA
3R22A:DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF PYRAZOLOPYRIDINE-SULFONAMIDES AS POTENT MULTIPLE-MITOTIC KINASE (MMK) INHIBITORS (PART I)
3UNZA:; B:AURORA A IN COMPLEX WITH RPM1679
3UO4A:AURORA A IN COMPLEX WITH RPM1680
3UO5A:AURORA A IN COMPLEX WITH YL1-038-31
3UO6A:; B:AURORA A IN COMPLEX WITH YL5-083
3UODA:AURORA A IN COMPLEX WITH RPM1693
3UOHA:; B:AURORA A IN COMPLEX WITH RPM1722
3UOJA:; B:AURORA A IN COMPLEX WITH RPM1715
3UOKA:; B:AURORA A IN COMPLEX WITH YL5-81-1
3UOLA:; B:AURORA A IN COMPLEX WITH SO2-162
3UP2A:AURORA A IN COMPLEX WITH RPM1686
3UP7A:AURORA A IN COMPLEX WITH YL1-038-09
3VAPA:SYNTHESIS AND SAR STUDIES OF IMIDAZO-[1,2-A]-PYRAZINE AURORA KINASE INHIBITORS WITH IMPROVED OFF TARGET KINASE SELECTIVITY
3W10A:AURORA KINASE A COMPLEXED TO PYRAZOLE AMINOQUINOLINE I
3W16A:STRUCTURE OF AURORA KINASE A COMPLEXED TO PYRAZOLE-AMINOQUINOLINE INHIBITOR III
3W18A:; B:STRUCTURE OF AURORA KINASE A COMPLEXED TO BENZOIMIDAZOLE-INDAZOLE INHIBITOR XIII
3W2CE:; G:STRUCTURE OF AURORA KINASE A COMPLEXED TO BENZOIMIDAZOLE-INDAZOLE INHIBITOR XV
4DEBA:AURORA A IN COMPLEX WITH RK2-17-01
4DEDA:AURORA A IN COMPLEX WITH YL1-038-21
4DEEA:AURORA A IN COMPLEX WITH ADP
4JAJA:CRYSTAL STRUCTURE OF AURORA KINASE A IN COMPLEX WITH BENZO[C][1, 8]NAPHTHYRIDIN-6(5H)-ONE
4JBOA:NOVEL AURORA KINASE INHIBITORS REVEAL MECHANISMS OF HURP IN NUCLEATION OF CENTROSOMAL AND KINETOCHORE MICROTUBULES
4JBPA:NOVEL AURORA KINASE INHIBITORS REVEAL MECHANISMS OF HURP IN NUCLEATION OF CENTROSOMAL AND KINETOCHORE MICROTUBULES
4JBQA:NOVEL AURORA KINASE INHIBITORS REVEAL MECHANISMS OF HURP IN NUCLEATION OF CENTROSOMAL AND KINETOCHORE MICROTUBULES
(-)
Protein domain: automated matches (542)
(-)
African clawed frog (Xenopus laevis) [TaxId: 8355] (9)
2BFXA:; B:MECHANISM OF AURORA-B ACTIVATION BY INCENP AND INHIBITION BY HESPERADIN.
2BFYA:; B:COMPLEX OF AURORA-B WITH INCENP AND HESPERADIN.
2VGOA:; B:CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REVERSINE INHIBITOR
2VGPA:; B:CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH A AMINOTHIAZOLE INHIBITOR
2VRXA:; B:STRUCTURE OF AURORA B KINASE IN COMPLEX WITH ZM447439
3ZTXA:; B:AURORA KINASE SELECTIVE INHIBITORS IDENTIFIED USING A TAXOL-INDUCED CHECKPOINT SENSITIVITY SCREEN.
4B8LA:AURORA B KINASE P353G MUTANT
4B8MA:; B:AURORA B KINASE IN COMPLEX WITH VX-680
4C2VB:AURORA B KINASE IN COMPLEX WITH THE SPECIFIC INHIBITOR BARASERTIB
(-)
Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932] (1)
2JD5A:; B:SKY1P BOUND TO NPL3P-DERIVED SUBSTRATE PEPTIDE
(-)
Chicken (Gallus gallus) [TaxId: 9031] (6)
2J0LA:CRYSTAL STRUCTURE OF A THE ACTIVE CONFORMATION OF THE KINASE DOMAIN OF FOCAL ADHESION KINASE WITH A PHOSPHORYLATED ACTIVATION LOOP.
2JKKA:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
2JKMA:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
2JKOA:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
4BRXA:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH A DIARYLAMINO-1,3,5-TRIAZINE INHIBITOR
4C7TA:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH A DIARYLAMINO-1,3,5-TRIAZINE INHIBITOR
(-)
Cow (Bos taurus) [TaxId: 9913] (27)
2C1AA:STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE
2C1BA:STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH ( 4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE
2JDSA:STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A-443654
2JDTA:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE
2JDVA:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654
2UVXA:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7-AZAINDOLE
2UVYA:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4-(9H-PURIN-6-YL)-BENZYL)-AMINE
2UVZA:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL-C-(4-( 9H-PURIN-6-YL)-PHENYL)-METHYLAMINE
2UW0A:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 6-(4-(4-(4-CHLORO-PHENYL)-PIPERIDIN-4-YL)-PHENYL)-9H-PURINE
2UW3A:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4-PHENYL-1H-PYRAZOLE
2UW4A:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2UW5A:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (R)-2-(4-CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2UW6A:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (S)-2-(4-CHLORO-PHENYL)-2-(4-1H-PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE
2UW7A:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE
2UW8A:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-CHLORO-PHENYL)-2-PHENYL-ETHYLAMINE
2UZTA:PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE INHIBITORS
2UZUE:PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
2UZVA:PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
2UZWE:PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS
2VNWA:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)PIPERIDIN-4-YL)METHANAMINE
2VNYA:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1-(9H-PURIN-6-YL)PIPERIDIN-4-YL)AMINE
2VO0A:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE
2VO3A:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-(4-(4-CHLOROPHENYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YL)METHYLAMINE
2VO6A:STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE
2VO7A:STRUCTURE OF PKA COMPLEXED WITH 4-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDIN-4-YLAMINE
3E8CA:; B:; C:; D:; E:; F:CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
3E8EA:; B:; E:; I:; L:; P:CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF PKA IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
(-)
Cryptosporidium parvum [TaxId: 353152] (2)
2QKRA:CRYPTOSPORIDIUM PARVUM CYCLIN-DEPENDENT KINASE CGD5_2510 WITH INDIRUBIN 3'-MONOXIME BOUND
3NIZA:CRYPTOSPORIDIUM PARVUM CYCLIN-DEPENDENT KINASE CGD5_2510 WITH ADP BOUND.
(-)
Human (Homo sapiens) [TaxId: 9606] (452)
1TVOA:THE STRUCTURE OF ERK2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1W7HA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W82A:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W83A:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W84A:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1WBNA:FRAGMENT BASED P38 INHIBITORS
1WBOA:FRAGMENT BASED P38 INHIBITORS
1WBSA:IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBTA:IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBVA:IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBWA:IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WVWA:CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WVXA:CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WVYA:CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WZYA:CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A PYRAZOLOPYRIDAZINE DERIVATIVE
1ZWSA:; B:; C:; D:; E:; F:; G:; H:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
2A27A:; B:; C:; D:; E:; F:; G:; H:HUMAN DRP-1 KINASE, W305S S308A D40 MUTANT, CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
2BIYA:STRUCTURE OF PDK1-S241A MUTANT KINASE DOMAIN
2BKZA:; C:STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
2BPMA:; C:STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
2BR1A:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRBA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRGA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRHA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRMA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRNA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BROA:STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2C3JA:IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C3KA:IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C3LA:IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C47A:; B:; C:; D:STRUCTURE OF CASEIN KINASE 1 GAMMA 2
2C4GA:; C:STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
2C6DA:AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP
2C6EA:; B:AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH A 5-AMINOPYRIMIDINYL QUINAZOLINE INHIBITOR
2CGUA:IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGVA:IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGWA:IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGXA:IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CHLA:STRUCTURE OF CASEIN KINASE 1 GAMMA 3
2CMWA:STRUCTURE OF HUMAN CASEIN KINASE 1 GAMMA-1 IN COMPLEX WITH 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE (CASP TARGET)
2DWBA:AURORA-A KINASE COMPLEXED WITH AMPPNP
2E2BA:; B:CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH INNO-406
2E9NA:STRUCTURE OF H-CHK1 COMPLEXED WITH A767085
2E9OA:STRUCTURE OF H-CHK1 COMPLEXED WITH AA582939
2E9PA:STRUCTURE OF H-CHK1 COMPLEXED WITH A771129
2E9UA:STRUCTURE OF H-CHK1 COMPLEXED WITH A780125
2E9VA:; B:STRUCTURE OF H-CHK1 COMPLEXED WITH A859017
2F4JA:STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL MUTANT IN COMPLEX WITH THE AURORA KINASE INHIBITOR VX-680
2FB8A:; B:STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885
2FSLX:MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-A
2FSMX:MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-B
2FSOX:MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A) ACTIVATING MUTANT
2FSTX:MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327L) ACTIVATING MUTANT
2G15A:STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C-MET KINASE
2G2HA:; B:A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
2GDOA:4-(AMINOALKYLAMINO)-3-BENZIMIDAZOLE-QUINOLINONES AS POTENT CHK1 INHIBITORS
2GQGA:; B:X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED ABL KINASE DOMAIN
2GU8A:DISCOVERY OF 2-PYRIMIDYL-5-AMIDOTHIOPHENES AS NOVEL AND POTENT INHIBITORS FOR AKT: SYNTHESIS AND SAR STUDIES
2HIWA:; B:CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALYTIC DOMAIN COMPLEXED WITH TYPE II INHIBITOR
2HXLA:CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1
2HXQA:CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2
2HY0A:CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 22
2I0EA:; B:STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR
2I0VA:C-FMS TYROSINE KINASE IN COMPLEX WITH A QUINOLONE INHIBITOR
2I0YA:CFMS TYROSINE KINASE (FGF KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
2I1MA:CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
2ITNA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AMP-PNP
2ITPA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788
2ITQA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AFN941
2ITTA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AEE788
2ITUA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AFN941
2ITVA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AMP-PNP
2ITWA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AFN941
2ITXA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
2ITZA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA
2IW8C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
2IZRA:STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZSA:STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZTA:STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZUA:STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2J5EA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 13-JAB
2J5FA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 34-JAB
2J6MA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AEE788
2J7TA:CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 BOUND TO SU11274
2J90A:; B:CRYSTAL STRUCTURE OF HUMAN ZIP KINASE IN COMPLEX WITH A TETRACYCLIC PYRIDONE INHIBITOR (PYRIDONE 6)
2JAMA:; B:CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE I G
2JBOA:PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-1, SOAKING)
2JC6A:; C:CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE 1D
2JEDA:; B:THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION.
2JITA:; B:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION
2JIUA:; B:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788
2NP8A:STRUCTURAL BASIS FOR THE INHIBITION OF AURORA A KINASE BY A NOVEL CLASS OF HIGH AFFINITY DISUBSTITUTED PYRIMIDINE INHIBITORS
2NPQA:A NOVEL LIPID BINDING SITE IN THE P38 ALPHA MAP KINASE
2OBJA:CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH INHIBITOR
2OGVA:CRYSTAL STRUCTURE OF THE AUTOINHIBITED HUMAN C-FMS KINASE DOMAIN
2OJGA:CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OJIA:CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OJJA:CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OO8X:SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS
2OSCA:SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS
2P4IA:; B:EVOLUTION OF A HIGHLY SELECTIVE AND POTENT 2-(PYRIDIN-2-YL)-1,3,5-TRIAZINE TIE-2 KINASE INHIBITOR
2R2PA:KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5)
2REIA:KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7)
2V7AA:; B:CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358
2W1DA:STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1EA:STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1FA:STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1GA:STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W4JA:X-RAY STRUCTURE OF A DAP-KINASE 2-277
2W4KA:X-RAY STRUCTURE OF A DAP-KINASE 2-302
2W5AA:HUMAN NEK2 KINASE ADP-BOUND
2W5BA:HUMAN NEK2 KINASE ATPGAMMAS-BOUND
2W5HA:HUMAN NEK2 KINASE APO
2W96B:CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W99B:CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W9FB:CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W9ZB:CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2WAJA:CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH A 1-ARYL-3,4-DIHYDROISOQUINOLINE INHIBITOR
2WGJA:X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET
2WIHA:; C:STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125
2WIPA:; C:STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H] QUINAZOLINE-3-CARBOXYLIC ACID
2WKMA:X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET
2WMQA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMRA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMSA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMTA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMUA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMVA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMWA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMXA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WPAA:; C:OPTIMISATION OF 6,6-DIMETHYL PYRROLO 3,4-C PYRAZOLES: IDENTIFICATION OF PHA-793887, A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING
2WQBA:STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A THIAZOLOPYRIMIDINE INHIBITOR
2WQOA:STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950
2WTVA:; B:; C:; D:AURORA-A INHIBITOR STRUCTURE
2WXVA:; C:STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(4,3-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR
2X0GA:X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX
2X6DA:AURORA-A BOUND TO AN INHIBITOR
2X81A:STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054
2X8DA:DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2X8IA:DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2XCHA:CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2XCKA:CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2XEYA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XEZA:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XF0A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XIXA:PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-1 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
2XIYA:PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-2 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
2XIZA:PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-3 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
2XJ0A:PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-4 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN
2XJ1A:PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE INIBITOR
2XK3A:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 35
2XK4A:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 17
2XK6A:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 36
2XK7A:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 23
2XK8A:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 15
2XKCA:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 14
2XKDA:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 12
2XKEA:STRUCTURE OF NEK2 BOUND TO AMINIPYRAZINE COMPOUND 5
2XKFA:STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 2
2XNEA:STRUCTURE OF AURORA-A BOUND TO AN IMIDAZOPYRAZINE INHIBITOR
2XNGA:STRUCTURE OF AURORA-A BOUND TO A SELECTIVE IMIDAZOPYRAZINE INHIBITOR
2XNMA:STRUCTURE OF NEK2 BOUND TO CCT
2XNNA:STRUCTURE OF NEK2 BOUND TO CCT242430
2XNOA:STRUCTURE OF NEK2 BOUND TO CCT243779
2XNPA:STRUCTURE OF NEK2 BOUND TO CCT244858
2XRUA:AURORA-A T288E COMPLEXED WITH PHA-828300
2XRWA:LINEAR BINDING MOTIFS FOR JNK AND FOR CALCINEURIN ANTAGONISTICALLY CONTROL THE NUCLEAR SHUTTLING OF NFAT4
2XUUA:CRYSTAL STRUCTURE OF A DAP-KINASE 1 MUTANT
2XYNA:; B:; C:HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680
2XZSA:; B:DEATH ASSOCIATED PROTEIN KINASE 1 RESIDUES 1-312
2Y0AA:STRUCTURE OF DAPK1 CONSTRUCT RESIDUES 1-304
2Y4PA:; B:; C:; D:DIMERIC STRUCTURE OF DAPK-1 CATALYTIC DOMAIN
2YAKA:STRUCTURE OF DEATH-ASSOCIATED PROTEIN KINASE 1 (DAPK1) IN COMPLEX WITH A RUTHENIUM OCTASPORINE LIGAND (OSV)
2YDIA:DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS
2YDKA:DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS
2YERA:SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 INHIBITORS
2YEXA:SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 INHIBITORS
2YISA:TRIAZOLOPYRIDINE INHIBITORS OF P38 KINASE.
2YIWA:TRIAZOLOPYRIDINE INHIBITORS OF P38 KINASE
2YIXA:TRIAZOLOPYRIDINE INHIBITORS OF P38
2YM3A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2YM4A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2YM5A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2YM6A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2YM7A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2YM8A:CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2ZAZA:CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH 4-ANILINO QUINOLINE INHIBITOR
2ZB0A:CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR
2ZB1A:CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR
2ZDTA:CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR
2ZDUA:CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR
2ZJWA:CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH ELLAGIC ACID
2ZOQA:; B:STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1
3A2CA:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)
3A4PA:HUMAN C-MET KINASE DOMAIN COMPLEXED WITH 6-BENZYLOXYQUINOLINE INHIBITOR
3AGLA:; B:COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1039
3AGMA:COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-670
3AMYA:CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH APIGENIN
3AXWA:CRYSTAL STRUCTURE OF HUMAN CK2ALPHA COMPLEXED WITH A POTENT INHIBITOR
3B2TA:; B:STRUCTURE OF PHOSPHOTRANSFERASE
3BBTB:; D:CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN COMPLEX WITH LAPATINIB
3BCEA:; B:; C:CRYSTAL STRUCTURE OF THE ERBB4 KINASE
3BEAA:CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH A PYRIMIDINOPYRIDONE INHIBITOR
3CC6A:CRYSTAL STRUCTURE OF KINASE DOMAIN OF PROTEIN TYROSINE KINASE 2 BETA (PTK2B)
3CIKA:186-549HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
3CLYA:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAINS TRAPPED IN TRANS-PHOSPHORYLATION REACTION
3COIA:CRYSTAL STRUCTURE OF P38DELTA KINASE
3CQUA:CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
3CQWA:CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
3CS9A:; B:; C:; D:HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
3D4QA:; B:PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE
3DFCB:CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH AMPPNP
3DGKA:CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN
3DKOA:COMPLEX BETWEEN THE KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) AND INHIBITOR ALW-II-49-7
3DPKA:CFMS TYROSINE KINASE IN COMPLEX WITH A PYRIDOPYRIMIDINONE INHIBITOR
3E7OA:; B:CRYSTAL STRUCTURE OF JNK2
3E92A:CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR
3E93A:CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR
3EH9A:CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH ADP
3EHAA:CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH AMPPNP
3ELJA:JNK1 COMPLEXED WITH A BIS-ANILINO-PYRROLOPYRIMIDINE INHIBITOR.
3ET7A:CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-2318841
3F5GA:CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH ADP AND MG2+
3F5UA:CRYSTAL STRUCTURE OF THE DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH AMPPNP AND MG2+
3FDNA:STRUCTURE-BASED DRUG DESIGN OF NOVEL AURORA KINASE A INHIBITORS: STRUCTURE BASIS FOR POTENCY AND SPECIFICITY
3FHRA:HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3 (MK3)-INHIBITOR COMPLEX
3FWQA:; B:INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
3FXWA:HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3/INHIBITOR 2 COMPLEX
3FZOA:CRYSTAL STRUCTURE OF PYK2-APO, PROLINE-RICH TYROSINE KINASE
3FZPA:CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH ATPGS
3FZRA:CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-431396
3FZSA:CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH BIRB796
3FZTA:CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-4618433
3G33A:; C:CRYSTAL STRUCTURE OF CDK4/CYCLIN D3
3GB2A:GSK3BETA INHIBITOR COMPLEX
3GC7A:THE STRUCTURE OF P38ALPHA IN COMPLEX WITH A DIHYDROQUINAZOLINONE
3GC8A:; B:THE STRUCTURE OF P38BETA C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE
3GC9A:; B:THE STRUCTURE OF P38BETA C119S, C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR
3GENA:THE 1.6 A CRYSTAL STRUCTURE OF HUMAN BRUTON'S TYROSINE KINASE BOUND TO A PYRROLOPYRIMIDINE-CONTAINING COMPOUND
3GP0A:CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 11 (P38 BETA) IN COMPLEX WITH NILOTINIB
3GQIA:CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
3GQLA:; B:; C:CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
3GU4A:CRYSTAL STRUCTURE OF DAPKQ23V-AMPPNP
3GU5A:CRYSTAL STRUCTURE OF DAPKQ23V-AMPPNP-MG2+
3GU6A:CRYSTAL STRUCTURE OF DAPKQ23V-ADP
3GU7A:CRYSTAL STRUCTURE OF DAPKQ23V-ADP-MG2+
3GU8A:CRYSTAL STRUCTURE OF DAPKL93G WITH N6-CYCLOPENTYLADENOSINE
3GUBA:CRYSTAL STRUCTURE OF DAPKL93G COMPLEXED WITH N6-(2-PHENYLETHYL)ADENOSINE
3GVUA:THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH GLEEVEC
3H3CA:CRYSTAL STRUCTURE OF PYK2 IN COMPLEX WITH SULFOXIMINE-SUBSTITUTED TRIFLUOROMETHYLPYRIMIDINE ANALOG
3H9RA:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TYPE I ACTIVIN RECEPTOR (ACVR1) IN COMPLEX WITH FKBP12 AND DORSOMORPHIN
3HA6A:CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH TPX2 AND COMPOUND 10
3HL7A:CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH SD-0006
3HLLA:CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH PH-797804
3HMIA:THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
3HP2A:CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIDINONE COMPOUND
3HP5A:CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIMIDOPYRIDAZINONE COMPOUND
3I5ZA:CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-N-(2-HYDROXY-1-PHENYLETHYL)-4-(5-METHYL-2-(PHENYLAMINO)PYRIMIDIN-4-YL)-1H-PYRROLE-2-CARBOXAMIDE
3I60A:CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-4-(2-(2-CHLOROPHENYLAMINO)-5-METHYLPYRIMIDIN-4-YL)-N-(2-HYDROXY-1-PHENYLETHYL)-1H-PYRROLE-2-CARBOXAMIDE
3IDPA:; B:B-RAF V600E KINASE DOMAIN IN COMPLEX WITH AN AMINOISOQUINOLINE INHIBITOR
3II5A:; B:THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE INHIBITOR
3IW4A:; B:; C:CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071
3K54A:STRUCTURES OF HUMAN BRUTON'S TYROSINE KINASE IN ACTIVE AND INACTIVE CONFORMATIONS SUGGESTS A MECHANISM OF ACTIVATION FOR TEC FAMILY KINASES.
3K5UA:IDENTIFICATION, SAR STUDIES AND X-RAY COCRYSTAL ANALYSIS OF A NOVEL FURANO-PYRIMIDINE AURORA KINASE A INHIBITOR
3KCFA:; B:; C:; D:; E:CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
3KF7A:CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A TRIAZOLOPYRIMIDINE COMPOUND
3KRJA:CFMS TYROSINE KINASE IN COMPLEX WITH 4-CYANO-1H-IMIDAZOLE-2-CARBOXYLIC ACID (2-CYCLOHEX-1-ENYL-4-PIPERIDIN-4-YL-PHENYL)-AMIDE
3KRLA:CFMS TYROSINE KINASE IN COMPLEX WITH 5-CYANO-FURAN-2-CARBOXYLIC ACID [4-(4-METHYL-PIPERAZIN-1-YL)-2-PIPERIDIN-1-YL-PHENYL]-AMIDE
3KRWA:186-549HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (SOAK)
3KRXA:186-549HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (CO-CRYSTAL)
3KULA:; B:KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8)
3L8PA:CRYSTAL STRUCTURE OF CYTOPLASMIC KINASE DOMAIN OF TIE2 COMPLEXED WITH INHIBITOR CEP11207
3LAUA:CRYSTAL STRUCTURE OF AURORA2 KINASE IN COMPLEX WITH A GSK3BETA INHIBITOR
3LCDA:INHIBITOR BOUND TO A DFG-IN STRUCTURE OF THE KINASE DOMAIN OF CSF-1R
3M11A:CRYSTAL STRUCTURE OF AURORA A KINASE COMPLEXED WITH INHIBITOR
3MBLA:CRYSTAL STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK 1) IN COMPLEX WITH LIGAND AND MGADP
3MDYA:; C:CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (BMPR1B) IN COMPLEX WITH FKBP12 AND LDN-193189
3MTFA:; B:CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH A 2-AMINOPYRIDINE INHIBITOR
3MV5A:CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES
3MVHA:CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES
3MVJA:; B:; E:HUMAN CYCLIC AMP-DEPENDENT PROTEIN KINASE PKA INHIBITOR COMPLEX
3MY0A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:; M:; N:; O:; P:; Q:; R:; S:; T:; U:; V:; W:; X:CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN-193189
3NAXA:PDK1 IN COMPLEX WITH INHIBITOR MP7
3NGAA:; B:HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH CX-4945
3NLBA:NOVEL KINASE PROFILE HIGHLIGHTS THE TEMPORAL BASIS OF CONTEXT DEPENDENT CHECKPOINT PATHWAYS TO CELL DEATH
3NPCA:; B:CRYSTAL STRUCTURE OF JNK2 COMPLEXED WITH BIRB796
3NX8A:HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH PHENOL
3O2MA:; B:CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM COMPLEX WITH A BIARYL TETRAZOL (A-82118)
3OCBA:; B:AKT1 KINASE DOMAIN WITH PYRROLOPYRIMIDINE INHIBITOR
3OCSA:CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI1746
3OCTA:CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE MUTANT V555R IN COMPLEX WITH DASATINIB
3OFMA:STRUCTURE OF A HUMAN CK2ALPHA PRIME, THE PARALOG ISOFORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM HOMO SAPIENS
3OG7A:; B:B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX4032
3OOGA:HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH A SMALL FRAGMENT
3OOMA:CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[1,2-B]PYRIDAZINE INHIBITOR K00507
3OW4A:; B:DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS
3OXTA:HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
3P08A:; B:CRYSTAL STRUCTURE OF THE HUMAN BTK KINASE DOMAIN
3P9JA:AURORA A KINASE DOMAIN WITH PHTHALAZINONE PYRAZOLE INHIBITOR
3PIXA:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-ISOPROPYL-7-(4-METHYL-PIPERAZIN-1-YL)-4-(5-METHYL-2H-PYRAZOL-3-YLAMINO)-2H-PHTHALAZIN-1-ONE
3PIYA:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH R406
3PIZA:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH (5-AMINO-1-O-TOLYL-1H-PYRAZOL-4-YL)-[3-(1-METHANESULFONYL-PIPERIDIN-4-YL)-PHENYL]-METHANONE
3PJ1A:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 3-(2,6-DICHLORO-PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-3,4-DIHYDRO-1H-PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE
3PJ2A:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-6-(4-FLUORO-PHENOXY)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3PJ3A:CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-METHYL-5-[(E)-(3-PHENYL-ACRYLOYL)AMINO]-N-(2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-BENZAMIDE
3PLSA:RON IN COMPLEX WITH LIGAND AMP-PNP
3POOA:HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
3PP0A:; B:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN HER2 (ERBB2).
3PP1A:CRYSTAL STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK 1) IN COMPLEX WITH LIGAND AND MGATP
3PRFA:; B:CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR
3PXKA:; B:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH PYRROLO[2,3-D]THIAZOLE
3PYYA:; B:DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE, SMALL-MOLECULE C-ABL KINASE ACTIVATOR THAT BINDS TO THE MYRISTOYL BINDING SITE
3PZEA:JNK1 IN COMPLEX WITH INHIBITOR
3Q4UA:; B:; C:; D:CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN-193189
3QKKA:SPIROCHROMANE AKT INHIBITORS
3QKLA:SPIROCHROMANE AKT INHIBITORS
3QKMA:SPIROCYCLIC SULFONAMIDES AS AKT INHIBITORS
3QRIA:; B:THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DCC-2036
3QRJA:; B:THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN T315I MUTANT IN COMPLEX WITH DCC-2036
3QRKA:THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DP-987
3R1NA:MK3 KINASE BOUND TO COMPOUND 5B
3R21A:DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF PYRAZOLOPYRIDINE-SULFONAMIDES AS POTENT MULTIPLE-MITOTIC KINASE (MMK) INHIBITORS (PART I)
3RI1A:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR2 KINASE IN COMPLEX WITH ARQ 069
3ROCA:CRYSTAL STRUCTURE OF HUMAN P38 ALPHA COMPLEXED WITH A PYRIMIDINONE COMPOUND
3SA0A:COMPLEX OF ERK2 WITH NORATHYRIOL
3SHEA:NOVEL ATP-COMPETITIVE MK2 INHIBITORS WITH POTENT BIOCHEMICAL AND CELL-BASED ACTIVITY THROUGHOUT THE SERIES
3SLSA:; B:CRYSTAL STRUCTURE OF HUMAN MEK-1 KINASE IN COMPLEX WITH UCB1353770 AND AMPPNP
3SXRA:; B:CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEX WITH DASATINIB
3SXSA:CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEXED WITH PP2
3TXOA:PKC ETA KINASE IN COMPLEX WITH A NAPHTHYRIDINE
3U6JA:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRAZOLONE INHIBITOR
3UE4A:; B:STRUCTURAL AND SPECTROSCOPIC ANALYSIS OF THE KINASE INHIBITOR BOSUTINIB BINDING TO THE ABL TYROSINE KINASE DOMAIN
3UYSA:; B:; C:; D:CRYSTAL STRUCTURE OF APO HUMAN CK1D
3UYTA:; B:; C:; D:CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P1 CRYSTAL FORM
3UZPA:; B:CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P21 CRYSTAL FORM
3V5WA:186-549HUMAN G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH SOLUBLE GBETAGAMMA SUBUNITS AND PAROXETINE
3V6RA:; B:DISCOVERY OF POTENT AND SELECTIVE COVALENT INHIBITORS OF JNK
3V6SA:; B:DISCOVERY OF POTENT AND SELECTIVE COVALENT INHIBITORS OF JNK
3VNTA:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH A [1, 3]THIAZOLO[5,4-B]PYRIDINE DERIVATIVE
3VO3A:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH IMIDAZO[1, 2-B]PYRIDAZINE DERIVATIVE
3W55A:THE STRUCTURE OF ERK2 IN COMPLEX WITH FR148083
3W8QA:STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1)
3ZBXA:X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR 6-((6-(4-FLUOROPHENYL)-(1,2,4)TRIAZOLO(4,3-B)(1,2,4)TRIAZIN-3-YL)METHYL)QUINOLINE.
3ZC5A:X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR ( S)-6-(1-(6-(1-METHYL-1H-PYRAZOL-4-YL)-(1,2,4)TRIAZOLO(4,3-B)PYRIDAZIN-3-YL)ETHYL)QUINOLINE.
3ZCLA:X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR ( S)-3-(1-(1H-PYRROLO(2,3-B)PYRIDIN-3-YL)ETHYL)-N-ISOPROPYL-( 1,2,4)TRIAZOLO(4,3-B)PYRIDAZIN-6-AMINE
3ZLSA:CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 6
3ZLWA:CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 3
3ZLXA:CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 18
3ZLYA:CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 8
3ZM4A:CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 1
3ZS5A:STRUCTURAL BASIS FOR KINASE SELECTIVITY OF THREE CLINICAL P38ALPHA INHIBITORS
3ZSGA:X-RAY STRUCTURE OF P38ALPHA BOUND TO TAK-715
3ZSHA:X-RAY STRUCTURE OF P38ALPHA BOUND TO SCIO-469
3ZSIA:X-RAY STRUCTURE OF P38ALPHA BOUND TO VX-745
3ZXTA:; B:; C:; D:DIMERIC STRUCTURE OF DAPK-1 CATALYTIC DOMAIN IN COMPLEX WITH AMPPCP-MG
3ZXZA:X-RAY STRUCTURE OF PF-04217903 BOUND TO THE KINASE DOMAIN OF C-MET
3ZYAA:HUMAN P38 MAP KINASE IN COMPLEX WITH 2-AMINO-PHENYLAMINO-DIBENZOSUBERONE
3ZZEA:CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH N'-((3Z)-4-CHLORO-7-METHYL-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)-2-(4-HYDROXYPHENYL)PROPANOHYDRAZIDE
4A4XA:NEK2-EDE BOUND TO CCT248662
4AA0A:P38ALPHA MAP KINASE BOUND TO CMPD 2
4ACCA:; B:GSK3B IN COMPLEX WITH INHIBITOR
4ACDA:; B:GSK3B IN COMPLEX WITH INHIBITOR
4ACGA:; B:GSK3B IN COMPLEX WITH INHIBITOR
4ACHA:; B:GSK3B IN COMPLEX WITH INHIBITOR
4AE6A:; B:STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT CALPHA 2
4AE9A:; B:STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT C ALPHA 2
4AF3A:HUMAN AURORA B KINASE IN COMPLEX WITH INCENP AND VX-680
4AFEA:NEK2 BOUND TO HYBRID COMPOUND 21
4AFJA:; B:5-ARYL-4-CARBOXAMIDE-1,3-OXAZOLES: POTENT AND SELECTIVE GSK-3 INHIBITORS
4AG8A:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH AXITINIB (AG-013736) (N-METHYL-2-(3-((E)-2-PYRIDIN-2-YL-VINYL)-1H- INDAZOL-6-YLSULFANYL)-BENZAMIDE)
4AGCA:CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH AXITINIB (AG-013736) (N-METHYL-2-( 3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDAZOL-6-YLSULFANYL)-BENZAMIDE)
4AGDA:CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SUNITINIB (SU11248) (N-2-DIETHYLAMINOETHYL)-5-((Z)-(5-FLUORO-2-OXO-1H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE)
4ALUA:BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1
4AOIA:CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( 3-((1H-PYRROLO(2,3-B)PYRIDIN-3-YL)METHYL)-(1,2,4)TRIAZOLO( 4,3-B)(1,2,4) TRIAZIN-6-YL)BENZONITRILE
4AOTA:; B:CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 (LOK) BOUND TO GW830263A
4AP7A:CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( (6-(4-FLUOROPHENYL)-(1,2,4)TRIAZOLO(4,3-B)(1,2,4)TRIAZIN-3-YL)METHYL) PHENOL
4ARKA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MAP KINASE KINASE 1 (MEK1) IN COMPLEX WITH A SMALL MOLECULE INHIBITOR AND ADP
4AS0A:CYCLOMETALATED PHTHALIMIDES AS PROTEIN KINASE INHIBITORS
4ASDA:CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SORAFENIB (BAY 43-9006)
4ASEA:CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH TIVOZANIB (AV-951)
4AU8A:; B:CRYSTAL STRUCTURE OF COMPOUND 4A IN COMPLEX WITH CDK5, SHOWING AN UNUSUAL BINDING MODE TO THE HINGE REGION VIA A WATER MOLECULE
4AWIA:HUMAN JNK1ALPHA KINASE WITH 4-PHENYL-7-AZAINDOLE IKK2 INHIBITOR.
4B0GA:COMPLEX OF AURORA-A BOUND TO AN IMIDAZOPYRIDINE-BASED INHIBITOR
4B4LA:CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT
4BC6A:CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 BOUND TO NOVEL BOSUTINIB ISOFORM 1, PREVIOUSLY THOUGHT TO BE BOSUTINIB
4BCFA:STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCGA:STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCHA:STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCIA:STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCJA:STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BGGA:; B:; C:; D:CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844
4BYIA:AURORA A KINASE BOUND TO A HIGHLY SELECTIVE IMIDAZOPYRIDINE INHIBITOR
4BYJA:AURORA A KINASE BOUND TO A HIGHLY SELECTIVE IMIDAZOPYRIDINE INHIBITOR
4BZNA:CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH A PYRROLO(1,2-A) PYRAZINONE INHIBITOR
4BZOA:CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH A PYRROLO-PYRAZINONE INHIBITOR
4C02A:CRYSTAL STRUCTURE OF HUMAN ACVR1 (ALK2) IN COMPLEX WITH FKBP12.6 AND DORSOMORPHIN
4DBNA:; B:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN B-RAF WITH A [1, 3]THIAZOLO[5,4-B]PYRIDINE DERIVATIVE
4DEAA:AURORA A IN COMPLEX WITH YL1-038-18
4DHFA:; B:STRUCTURE OF AURORA A MUTANT BOUND TO BIOGENIDEC CPD 15
4DYMA:CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[1,2-B]PYRIDAZINE INHIBITOR K00135
4E26A:; B:BRAF IN COMPLEX WITH AN ORGANIC INHIBITOR 7898734
4EKLA:AKT1 WITH GDC0068
4EQUA:; B:HUMAN STK-10 (LOK) KINASE DOMAIN IN DFG-OUT CONFORMATION WITH INHIBITOR DSA-7
4EXU  [entry was replaced by entry 4YNO without any SCOP domain information]
4EYJA:MAPK13 COMPLEX WITH INHIBITOR
4EYMA:MAPK13 COMPLEX WITH INHIBITOR
4EZ5A:CDK6 (MONOMERIC) IN COMPLEX WITH INHIBITOR
4FC0A:; B:CRYSTAL STRUCTURE OF HUMAN KINASE DOMAIN OF B-RAF WITH A DFG-OUT INHIBITOR
4FG7A:CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I 1-293 IN COMPLEX WITH ATP
4FG8A:; B:CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I 1-315 IN COMPLEX WITH ATP
4FG9A:; B:CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I 1-320 IN COMPLEX WITH ATP
4FGBA:CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I APO FORM
4FUXA:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E75
4FUYA:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK2
4FV0A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK3
4FV1A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK4
4FV2A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK5
4FV3A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK6
4FV4A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK7
4FV5A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK9
4FV6A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E57
4FV7A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E94
4FV8A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E63
4FV9A:CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E71
4G16A:CRYSTAL STRUCTURE OF CK1G3 WITH 2-[(4-{[3-(TRIFLUOROMETHYL)PYRIDIN2-YL]OXY}PHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE
4G17A:CRYSTAL STRUCTURE OF CK1G3 WITH 2-[(4-TERT-BUTYLPHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE
4G5JA:CRYSTAL STRUCTURE OF EGFR KINASE IN COMPLEX WITH BIBW2992
4G5PA:; B:CRYSTAL STRUCTURE OF EGFR KINASE T790M IN COMPLEX WITH BIBW2992
4G6NA:CRYSTAL STRUCTURE OF THE ERK2
4G6OA:CRYSTAL STRUCTURE OF THE ERK2
4GG5A:CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
4GG7A:CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR
4GV1A:PKB ALPHA IN COMPLEX WITH AZD5363
4H1JA:CRYSTAL STRUCTURE OF PYK2 WITH THE PYRAZOLE 13A
4H1MA:CRYSTAL STRUCTURE OF PYK2 WITH THE INDOLE 10C
4H58A:; B:; C:BRAF IN COMPLEX WITH COMPOUND 3
4HGLA:CRYSTAL STRUCTURE OF CK1G3 WITH COMPOUND 1
4HGSA:CRYSTAL STRUCTURE OF CK1GS WITH COMPOUND 13
4HNIA:; B:CRYSTAL STRUCTURE OF CK1E IN COMPLEX WITH PF4800567
4HOKA:; C:; E:; G:; I:; K:; M:; O:; Q:; S:; U:; W:CRYSTAL STRUCTURE OF APO CK1E
4HVSA:CRYSTAL STRUCTURE OF KIT KINASE DOMAIN WITH A SMALL MOLECULE INHIBITOR, PLX647
4HW7A:CRYSTAL STRUCTURE OF FMS KINASE DOMAIN WITH A SMALL MOLECULAR INHIBITOR, PLX647-OME
4I41A:CRYSTAL STRUCTURE OF HUMAN SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE
4IMYA:; C:; E:THE AFF4 SCAFFOLD BINDS HUMAN P-TEFB ADJACENT TO HIV TAT
4IZ5A:; B:; C:; D:STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15
4IZ7A:; C:STRUCTURE OF NON-PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN
4IZAA:; C:STRUCTURE OF DUALLY PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN
4K33A:CRYSTAL STRUCTURE OF FGF RECEPTOR 3 (FGFR3) KINASE DOMAIN HARBORING THE K650E MUTATION, A GAIN-OF-FUNCTION MUTATION RESPONSIBLE FOR THANATOPHORIC DYSPLASIA TYPE II AND SPERMATOCYTIC SEMINOMA
4KSPA:; B:CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR TAK-632
4L7FA:CO-CRYSTAL STRUCTURE OF JNK1 AND AX13587
4NM5A:CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED WNT RECEPTOR LRP6 C-MOTIF
4NWMA:; B:CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-809959 AKA 4-TERT-BUTYL-N-[2-ME THYL-3-(6-{[4-(MORPHOLINE-4-CARBONYL)PHENYL]AMINO}-9H- PURIN-2-YL)PHENYL]BENZAMIDE
(-)
Maize (Zea mays) [TaxId: 4577] (1)
4ANMA:COMPLEX OF CK2 WITH A CDC7 INHIBITOR
(-)
Mouse (Mus musculus) [TaxId: 10090] (33)
2HELA:CRYSTAL STRUCTURE OF A MUTANT EPHA4 KINASE DOMAIN (Y742A)
2HENA:; B:; C:; D:CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP
2QOHA:; B:CRYSTAL STRUCTURE OF ABL KINASE BOUND WITH PPY-A
2XYUA:CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH VUF 12058
2Y6MA:CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN
2Y6OA:CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH DASATINIB.
2YA9A:; B:CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2
2YAAA:; B:CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH ATP
2YABA:; B:CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH AMP
2Z60A:CRYSTAL STRUCTURE OF THE T315I MUTANT OF ABL KINASE BOUND WITH PPY-A
3D14A:CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH 1-{5-[2-(THIENO[3,2-D]PYRIMIDIN-4-YLAMINO)-ETHYL]- THIAZOL-2-YL}-3-(3-TRIFLUOROMETHYL-PHENYL)-UREA
3D15A:CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH 1-(3-CHLORO-PHENYL)-3-{5-[2-(THIENO[3,2-D]PYRIMIDIN-4-YLAMINO)- ETHYL]-THIAZOL-2-YL}-UREA [SNS-314]
3D2IA:CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH 1-{5-[2-(1-METHYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7-YLAMINO)-ETHYL]-THIAZOL-2-YL}-3-(3-TRIFLUOROMETHYL-PHENYL)-UREA
3D2KA:CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH [7-(2-{2-[3-(3-CHLORO-PHENYL)-UREIDO]-THIAZOL-5-YL}-ETHYLAMINO)-PYRAZOLO[4,3-D]PYRIMIDIN-1-YL]-ACETIC ACID
3DAJA:CRYSTAL STRUCTURE OF AURORA A COMPLEXED WITH AN INHIBITOR DISCOVERED THROUGH SITE-DIRECTED DYNAMIC TETHERING
3DJ5A:CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH COMPOUND 290.
3DJ6A:CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH COMPOUND 823.
3DJ7A:CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH COMPOUND 130.
3DK3A:; B:CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
3DK6A:; B:CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
3DK7A:; B:CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT
3IDBA:CRYSTAL STRUCTURE OF (108-268)RIIB:C HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE
3IDCA:CRYSTAL STRUCTURE OF (102-265)RIIB:C HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE
3IK3A:; B:AP24534, A PAN-BCR-ABL INHIBITOR FOR CHRONIC MYELOID LEUKEMIA, POTENTLY INHIBITS THE T315I MUTANT AND OVERCOMES MUTATION-BASED RESISTANCE
3K5VA:; B:STRUCTURE OF ABL KINASE IN COMPLEX WITH IMATINIB AND GNF-2
3KF4A:; B:STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
3KFAA:; B:STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE
3MS9A:; B:ABL KINASE IN COMPLEX WITH IMATINIB AND A FRAGMENT (FRAG1) IN THE MYRISTATE POCKET
3MSSA:; B:; C:; D:ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE
3O7LB:; D:CRYSTAL STRUCTURE OF PHOSPHOLAMBAN (1-19):PKA C-SUBUNIT:AMP-PNP:MG2+ COMPLEX
3OXZA:CRYSTAL STRUCTURE OF ABL KINASE DOMAIN BOUND WITH A DFG-OUT INHIBITOR AP24534
3OY3A:; B:CRYSTAL STRUCTURE OF ABL T315I MUTANT KINASE DOMAIN BOUND WITH A DFG-OUT INHIBITOR AP24589
3TNPC:; F:STRUCTURE AND ALLOSTERY OF THE PKA RIIB TETRAMERIC HOLOENZYME
(-)
Mycobacterium tuberculosis [TaxId: 1773] (2)
3F61A:CRYSTAL STRUCTURE OF M. TUBERCULOSIS PKNB LEU33ASP/VAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
3F69A:; B:CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS PKNB MUTANT KINASE DOMAIN IN COMPLEX WITH KT5720
(-)
Mycobacterium tuberculosis [TaxId: 419947] (7)
3ORIA:; B:; C:; D:MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 1)
3ORKA:MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 2)
3ORLA:MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 3)
3ORMA:MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN D76A MUTANT
3OROA:MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 4)
3ORPA:MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 5)
3ORTA:MYCOBACTERIUM TUBERCULOSIS PKNB KINASE DOMAIN L33D MUTANT (CRYSTAL FORM 6)
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (1)
4I5HA:CRYSTAL STRUCTURE OF A DOUBLE MUTANT RAT ERK2 COMPLEXED WITH A TYPE II QUINAZOLINE INHIBITOR
(-)
Oryza sativa [TaxId: 39947] (1)
3SV0A:CRYSTAL STRUCTURE OF CASEIN KINASE-1 LIKE PROTEIN IN PLANT
(-)
Protein domain: B-Raf kinase (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1UWHA:; B:THE COMPLEX OF WILD TYPE B-RAF AND BAY439006
1UWJA:; B:THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006
(-)
Protein domain: Bruton's tyrosine kinase (Btk) (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1K2PA:; B:CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE DOMAIN
(-)
Protein domain: c-jun N-terminal kinase (jnk3s) (29)
(-)
Human (Homo sapiens) [TaxId: 9606] (29)
1JNKA:THE C-JUN N-TERMINAL KINASE (JNK3S) COMPLEXED WITH MGAMP-PNP
1PMNA:CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE INHIBITOR
1PMQ  [entry was replaced by entry 4Z9L without any SCOP domain information]
1PMUA:THE CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH A PHENANTROLINE INHIBITOR
1PMVA:THE STRUCTURE OF JNK3 IN COMPLEX WITH A DIHYDROANTHRAPYRAZOLE INHIBITOR
2B1PA:INHIBITOR COMPLEX OF JNK3
2EXCX:INHIBITOR COMPLEX OF JNK3
2O0UA:CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-{3-CYANO-6-[3-(1-PIPERIDINYL)PROPANOYL]-4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDIN-2-YL}-1-NAPHTHALENECARBOXAMIDE
2O2UA:CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-(3-CYANO-4,5,6,7-TETRAHYDRO-1-BENZOTHIEN-2-YL)-2-FLUOROBENZAMIDE
2OK1A:CRYSTAL STRUCTURE OF JNK3 BOUND TO N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2P33A:SYNTHESIS AND SAR OF AMINOPYRIMIDINES AS NOVEL C-JUN N-TERMINAL KINASE (JNK) INHIBITORS
2R9SA:; B:C-JUN N-TERMINAL KINASE 3 WITH 3,5-DISUBSTITUTED QUINOLINE INHIBITOR
3CGFA:IRAK-4 INHIBITORS (PART II)- A STRUCTURE BASED ASSESSMENT OF IMIDAZO[1,2 A]PYRIDINE BINDING
3CGOA:IRAK-4 INHIBITORS (PART II)- A STRUCTURE BASED ASSESSMENT OF IMIDAZO[1,2 A]PYRIDINE BINDING
3DA6A:CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-(3-METHYL-4-(3-(2-(METHYLAMINO)PYRIMIDIN-4-YL)PYRIDIN-2-YLOXY) NAPHTHALEN-1-YL)-1H-BENZO[D]IMIDAZOL-2-AMINE
3FI2A:CRYSTAL STRUCTURE OF JNK3 WITH AMINO-PYRAZOLE INHIBITOR, SR-3451
3FI3A:CRYSTAL STRUCTURE OF JNK3 WITH INDAZOLE INHIBITOR, SR-3737
3FV8A:JNK3 BOUND TO PIPERAZINE AMIDE INHIBITOR, SR2774.
3G90X:JNK-3 BOUND TO (Z)-5-FLUORO-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL) METHYL)-3-(HYDROXYIMINO)INDOLIN-2-ONE
3G9LX:JNK3 BOUND TO (Z)-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL)METHYL)-3-(HYDROXYIMINO)-4-STYRYLINDOLIN-2-ONE
3G9NA:JNK3 BOUND TO (Z)-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL)METHYL)-3-(HYDROXYIMINO)-4-PHENYLINDOLIN-2-ONE
3KVXA:JNK3 BOUND TO AMINOPYRIMIDINE INHIBITOR, SR-3562
3OXIA:DESIGN AND SYNTHESIS OF DISUBSTITUTED THIOPHENE AND THIAZOLE BASED INHIBITORS OF JNK FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
3OY1A:HIGHLY SELECTIVE C-JUN N-TERMINAL KINASE (JNK) 2 AND 3 INHIBITORS WITH IN VITRO CNS-LIKE PHARMACOKINETIC PROPERTIES
3PTGA:DESIGN AND SYNTHESIS OF A NOVEL, ORALLY EFFICACIOUS TRI-SUBSTITUTED THIOPHENE BASED JNK INHIBITOR
3RTPA:DESIGN AND SYNTHESIS OF BRAIN PENETRANT SELECTIVE JNK INHIBITORS WITH IMPROVED PHARMACOKINETIC PROPERTIES FOR THE PREVENTION OF NEURODEGENERATION
3TTIA:CRYSTAL STRUCTURE OF JNK3 COMPLEXED WITH CC-930, AN ORALLY ACTIVE ANTI-FIBROTIC JNK INHIBITOR
3TTJA:CRYSTAL STRUCTURE OF JNK3 COMPLEXED WITH CC-359, A JNK INHIBITOR FOR THE PREVENTION OF ISCHEMIA-REPERFUSION INJURY
4H36A:CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH ATF2 PEPTIDE
(-)
Protein domain: c-KIT receptor (5)
(-)
Human (Homo sapiens) [TaxId: 9606] (5)
1PKGA:; B:STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX
1T45A:STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE
1T46A:STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE
3G0EA:KIT KINASE DOMAIN IN COMPLEX WITH SUNITINIB
3G0FA:; B:KIT KINASE DOMAIN MUTANT D816H IN COMPLEX WITH SUNITINIB
(-)
Protein domain: c-src tyrosine kinase (46)
(-)
Chicken (Gallus gallus) [TaxId: 9031] (34)
2HWOA:; B:CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR
2HWPA:; B:CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVALENT INHIBITOR PD168393
2OIQA:; B:CRYSTAL STRUCTURE OF CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH THE CANCER DRUG IMATINIB.
2PTKA:249-528CHICKEN SRC TYROSINE KINASE
2QI8A:; B:CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN
2QLQA:; B:CRYSTAL STRUCTURE OF SRC KINASE DOMAIN WITH COVALENT INHIBITOR RL3
2QQ7A:; B:CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN WITH IRREVERSIBLE INHIBITOR
3D7TB:STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
3DQWA:; B:; C:; D:C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS
3DQXA:; B:CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH ATPGS
3EL7A:CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 3
3EL8A:; B:CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDINE 5
3EN4A:; B:TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP121, A MULTITARGETED KINASE INHIBITOR
3EN5A:; B:TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP494, A MULTITARGETED KINASE INHIBITOR
3EN6A:; B:TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH PP102, A MULTITARGETED KINASE INHIBITOR
3EN7A:; B:TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KINASE DOMAIN IN COMPLEX WITH S1, A MULTITARGETED KINASE INHIBITOR
3F6XA:; B:; C:; D:C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3G6GA:; B:EQUALLY POTENT INHIBITION OF C-SRC AND ABL BY COMPOUNDS THAT RECOGNIZE INACTIVE KINASE CONFORMATIONS
3G6HA:; B:SRC THR338ILE INHIBITED IN THE DFG-ASP-OUT CONFORMATION
3GEQA:; B:STRUCTURAL BASIS FOR THE CHEMICAL RESCUE OF SRC KINASE ACTIVITY
3OEZA:; B:CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH IMATINIB
3OF0A:; B:CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC TYROSINE KINASE DOMAIN
3QLFA:; B:CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH PYRAZOLOPYRIMIDINE 5
3QLGA:; B:CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE KINASE DOMAIN COMPLEXED WITH DASATINIB
3SVVA:; B:CRYSTAL STRUCTURE OF T338C C-SRC COVALENTLY BOUND TO VINYLSULFONAMIDE-PYRAZOLOPYRIMIDINE 9
3TZ9A:; B:KINASE DOMAIN OF CSRC IN COMPLEX WITH RL130
3U4WA:SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC4B
3U51A:; B:SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC1
3UQFA:; B:C-SRC KINASE DOMAIN IN COMPLEX WITH BKI RM-1-89
3UQGA:; B:C-SRC KINASE DOMAIN IN COMPLEX WITH BUMPLESS BKI ANALOG UW1243
4DGGA:; B:C-SRC KINASE DOMAIN IN COMPLEX WITH RM-1-176
4LGGA:; B:STRUCTURE OF 3MB-PP1 BOUND TO ANALOG-SENSITIVE SRC KINASE
4LGHA:; B:CRYSTAL STRUCTURE OF 1NM-PP1 BOUND TO ANALOG-SENSITIVE SRC KINASE
4MCVA:; B:STAR 12 BOUND TO ANALOG-SENSITIVE SRC KINASE
(-)
Human (Homo sapiens) [TaxId: 9606] (12)
1FMKA:249-533CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC
1KSWA:249-533STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) IN COMPLEX WITH N6-BENZYL ADP
1Y57A:249-533STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR
2BDFA:; B:SRC KINASE IN COMPLEX WITH INHIBITOR AP23451
2BDJA:SRC KINASE IN COMPLEX WITH INHIBITOR AP23464
2H8HA:249-529SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR
2SRCA:249-533CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP
4K11A:249-531THE STRUCTURE OF 1NA IN COMPLEX WITH SRC T338G
4MXOA:; B:HUMAN SRC KINASE BOUND TO KINASE INHIBITOR BOSUTINIB
4MXXA:; B:HUMAN SRC A403T MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
4MXYA:; B:SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
4MXZA:; B:SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB
(-)
Protein domain: Calmodulin-dependent protein kinase (1)
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (1)
1A06A:CALMODULIN-DEPENDENT PROTEIN KINASE FROM RAT
(-)
Protein domain: cAMP-dependent PK, catalytic subunit (75)
(-)
Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932] (1)
1FOTA:STRUCTURE OF THE UNLIGANDED CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT FROM SACCHAROMYCES CEREVISIAE
(-)
Cow (Bos taurus) [TaxId: 9913] (39)
1Q24A:PKA DOUBLE MUTANT MODEL OF PKB IN COMPLEX WITH MGATP
1Q61A:PKA TRIPLE MUTANT MODEL OF PKB
1Q62A:PKA DOUBLE MUTANT MODEL OF PKB
1Q8TA:THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH RHO-KINASE INHIBITOR Y-27632
1Q8UA:THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR H-1152P
1Q8WA:THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH RHO-KINASE INHIBITOR FASUDIL (HA-1077)
1SMHA:PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED N-TERMINAL HELIX
1STCE:CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH STAUROSPORINE
1SVEA:CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 1
1SVGA:CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 4
1SVHA:CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 8
1SZMA:; B:DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA)
1VEBA:CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH AZEPANE DERIVATIVE 5
1XH4A:CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XH5A:CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XH6A:CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XH7A:CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XH8A:CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XH9A:CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1XHAA:CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORS IN COMPLEX WITH PROTEIN KINASE A AND MUTANTS
1YDRE:STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H7 PROTEIN KINASE INHIBITOR 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE
1YDSE:STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H8 PROTEIN KINASE INHIBITOR [N-(2-METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE
1YDTE:STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE
2F7EE:PKA COMPLEXED WITH (S)-2-(1H-INDOL-3-YL)-1-(5-ISOQUINOLIN-6-YL-PYRIDIN-3-YLOXYMETHYL-ETYLAMINE
2F7XE:PROTEIN KINASE A BOUND TO (S)-2-(1H-INDOL-3-YL)-1-[5-((E)-2-PYRIDIN-4-YL-VINYL)-PYRIDIN-3-YLOXYMETHYL]-ETHYLAMINE
2F7ZE:PROTEIN KINASE A BOUND TO (R)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE
2GFCA:CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
2GNFA:PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632
2GNGA:PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE
2GNHA:PKA FIVE FOLD MUTANT MODEL OF RHO-KINASE WITH H1152P
2GNIA:PKA FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR FASUDIL (HA1077)
2GNJA:PKA THREE FOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632
2GNLA:PKA THREEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR H-1152P
2OH0E:CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH PYRIDINE-PYRAZOLOPYRIDINE BASED INHIBITORS
2OJFE:CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITH PYRIDINE-PYRAZOLOPYRIDINE BASED INHIBITORS
3AG9A:; B:COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1012
3BWJA:COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR LEAD COMPOUND ARC-1034
3DNDA:CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
3DNEA:CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24
(-)
Mouse (Mus musculus) [TaxId: 10090] (25)
1APME:2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT
1ATPE:2.2 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH MNATP AND A PEPTIDE INHIBITOR
1BKXA:A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND ADENOSINE FURTHER DEFINES CONFORMATIONAL FLEXIBILITY
1BX6A:CRYSTAL STRUCTURE OF THE POTENT NATURAL PRODUCT INHIBITOR BALANOL IN COMPLEX WITH THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
1FMOE:CRYSTAL STRUCTURE OF A POLYHISTIDINE-TAGGED RECOMBINANT CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH THE PEPTIDE INHIBITOR PKI(5-24) AND ADENOSINE
1J3HA:; B:CRYSTAL STRUCTURE OF APOENZYME CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT
1JBPE:CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A SUBSTRATE PEPTIDE, ADP AND DETERGENT
1JLUE:CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PHOSPHORYLATED SUBSTRATE PEPTIDE AND DETERGENT
1L3RE:CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
1RDQE:HYDROLYSIS OF ATP IN THE CRYSTAL OF Y204A MUTANT OF CAMP-DEPENDENT PROTEIN KINASE
1RE8A:CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 2
1REJA:CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 1
1REKA:CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH BALANOL ANALOG 8
1SYKA:; B:CRYSTAL STRUCTURE OF E230Q MUTANT OF CAMP-DEPENDENT PROTEIN KINASE REVEALS UNEXPECTED APOENZYME CONFORMATION
2CPKE:CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT PROTEIN KINASE
2ERZE:CRYSTAL STRUCTURE OF C-AMP DEPENDENT KINASE (PKA) BOUND TO HYDROXYFASUDIL
2QCSA:A COMPLEX STRUCTURE BETWEEN THE CATALYTIC AND REGULATORY SUBUNIT OF PROTEIN KINASE A THAT REPRESENTS THE INHIBITED STATE
2QURA:CRYSTAL STRUCTURE OF F327A/K285P MUTANT OF CAMP-DEPENDENT PROTEIN KINASE
2QVSE:CRYSTAL STRUCTURE OF TYPE IIA HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE
3FHIA:CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE CATALYTIC AND REGULATORY (RI{ALPHA}) SUBUNITS OF PKA
3FJQE:CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA IN COMPLEX WITH PEPTIDE INHIBITOR PKI ALPHA (6-25)
3OW3A:DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS
3QALE:CRYSTAL STRUCTURE OF ARG280ALA MUTANT OF CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
3QAME:CRYSTAL STRUCTURE OF GLU208ALA MUTANT OF CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE
4DFYA:; E:CRYSTAL STRUCTURE OF R194A MUTANT OF CAMP-DEPENDENT PROTEIN KINASE WITH UNPHOSPHORYLATED ACTIVATION LOOP
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (1)
3TNQB:STRUCTURE AND ALLOSTERY OF THE PKA RIIB TETRAMERIC HOLOENZYME
(-)
Pig (Sus scrofa) [TaxId: 9823] (9)
1CDKA:; B:CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (E.C.2.7.1.37) (PROTEIN KINASE A) COMPLEXED WITH PROTEIN KINASE INHIBITOR PEPTIDE FRAGMENT 5-24 (PKI(5-24) ISOELECTRIC VARIANT CA) AND MN2+ ADENYLYL IMIDODIPHOSPHATE (MNAMP-PNP) AT PH 5.6 AND 7C AND 4C
1CMKE:CRYSTAL STRUCTURES OF THE MYRISTYLATED CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE REVEAL OPEN AND CLOSED CONFORMATIONS
1CTPE:STRUCTURE OF THE MAMMALIAN CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND AN INHIBITOR PEPTIDE DISPLAYS AN OPEN CONFORMATION
3AMAA:PROTEIN KINASE A SIXFOLD MUTANT MODEL OF AURORA B WITH INHIBITOR JNJ-7706621
3AMBA:PROTEIN KINASE A SIXFOLD MUTANT MODEL OF AURORA B WITH INHIBITOR VX-680
3L9LA:; B:CRYSTAL STRUCTURE OF PKA WITH COMPOUND 36
3L9MA:; B:CRYSTAL STRUCTURE OF PKAB3 (PKA TRIPLE MUTANT V123A, L173M, Q181K) WITH COMPOUND 18
3L9NA:CRYSTAL STRUCTURE OF PKAB3 (PKA TRIPLE MUTANT V123A, L173M, Q181K) WITH COMPOUND 27
3P0MA:HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR
(-)
Protein domain: Carboxyl-terminal src kinase (csk) (4)
(-)
Human (Homo sapiens) [TaxId: 9606] (4)
1BYGA:KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLEX WITH INHIBITOR STAUROSPORINE
1K9AA:178-450; B:178-450; C:178-450; D:178-450; E:178-450; F:178-450CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL SRC KINASE AT 2.5 A RESOLUTION
3D7TA:STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
3D7UA:188-448; C:188-448STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
(-)
Protein domain: Casein kinase-1, CK1 (12)
(-)
Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896] (3)
1CSNA:BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP
1EH4A:; B:BINARY COMPLEX OF CASEIN KINASE-1 FROM S. POMBE WITH AN ATP COMPETITIVE INHIBITOR, IC261
2CSNA:BINARY COMPLEX OF CASEIN KINASE-1 WITH CKI7
(-)
Human (Homo sapiens) [TaxId: 9606] (6)
4HGTA:; B:CRYSTAL STRUCTURE OF CK1D WITH COMPOUND 13
4HNFA:; B:CRYSTAL STRUCTURE OF CK1D IN COMPLEX WITH PF4800567
4KB8A:; B:; C:; D:CK1D IN COMPLEX WITH 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE LIGAND
4KBAA:; C:; D:; B:CK1D IN COMPLEX WITH 9-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]-2,3,4,5-TETRAHYDROPYRIDO[2,3-F][1,4]OXAZEPINE INHIBITOR
4KBCA:; B:CK1D IN COMPLEX WITH {4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}METHANOL INHIBITOR
4KBKA:; B:; C:; D:CK1D IN COMPLEX WITH (3S)-3-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}MORPHOLINE INHIBITOR
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
4JJRA:; B:A P21 CRYSTAL FORM OF MAMMALIAN CASEIN KINASE 1 DELTA
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (2)
1CKIA:; B:RECOMBINANT CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317
1CKJA:; B:CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317 COMPLEX WITH BOUND TUNGSTATE
(-)
Protein domain: Cell cycle checkpoint kinase chk1 (57)
(-)
Human (Homo sapiens) [TaxId: 9606] (57)
1IA8A:THE 1.7 A CRYSTAL STRUCTURE OF HUMAN CELL CYCLE CHECKPOINT KINASE CHK1
1NVQA:THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/UCN-01
1NVRA:THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/STAUROSPORINE
1NVSA:THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/SB218078
1ZLTA:CRYSTAL STRUCTURE OF CHK1 COMPLEXED WITH A HYMENALDISINE ANALOG
1ZYSA:CO-CRYSTAL STRUCTURE OF CHECKPOINT KINASE CHK1 WITH A PYRROLO-PYRIDINE INHIBITOR
2AYPA:CRYSTAL STRUCTURE OF CHK1 WITH AN INDOL INHIBITOR
2GHGA:2-270H-CHK1 COMPLEXED WITH A431994
2HOGA:CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 20
2QHMA:CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2A
2QHNA:CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1A
2R0UA:CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 54
2X8EA:DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2YDJA:; B:DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS
2YWPA:CRYSTAL STRUCTURE OF CHK1 WITH A UREA INHIBITOR
3F9NA:CRYSTAL STRUCTURE OF CHK1 KINASE IN COMPLEX WITH INHIBITOR 38
3JVRA:CHARACTERIZATION OF THE CHK1 ALLOSTERIC INHIBITOR BINDING SITE
3JVSA:CHARACTERIZATION OF THE CHK1 ALLOSTERIC INHIBITOR BINDING SITE
3OT3A:X-RAY CRYSTAL STRUCTURE OF COMPOUND 22K BOUND TO HUMAN CHK1 KINASE DOMAIN
3OT8A:X-RAY CRYSTAL STRUCTURE OF COMPOUND 17R BOUND TO HUMAN CHK1 KINASE DOMAIN
3PA3A:X-RAY CRYSTAL STRUCTURE OF COMPOUND 70 BOUND TO HUMAN CHK1 KINASE DOMAIN
3PA4A:X-RAY CRYSTAL STRUCTURE OF COMPOUND 2A BOUND TO HUMAN CHK1 KINASE DOMAIN
3PA5A:X-RAY CRYSTAL STRUCTURE OF COMPOUND 1 BOUND TO HUMAN CHK1 KINASE DOMAIN
3TKHA:CRYSTAL STRUCTURE OF CHK1 IN COMPLEX WITH INHIBITOR S01
3TKIA:CRYSTAL STRUCTURE OF CHK1 IN COMPLEX WITH INHIBITOR S25
3U9NA:X-RAY CRYSTAL STRUCTURE OF COMPOUND 1 BOUND TO HUMAN CHK1 KINASE DOMAIN
4FSMA:CRYSTAL STRUCTURE OF THE CHK1
4FSNA:CRYSTAL STRUCTURE OF THE CHK1
4FSQA:CRYSTAL STRUCTURE OF THE CHK1
4FSRA:CRYSTAL STRUCTURE OF THE CHK1
4FSTA:CRYSTAL STRUCTURE OF THE CHK1
4FSUA:CRYSTAL STRUCTURE OF THE CHK1
4FSWA:CRYSTAL STRUCTURE OF THE CHK1
4FSYA:CRYSTAL STRUCTURE OF THE CHK1
4FSZA:CRYSTAL STRUCTURE OF THE CHK1
4FT0A:CRYSTAL STRUCTURE OF THE CHK1
4FT3A:CRYSTAL STRUCTURE OF THE CHK1
4FT5A:CRYSTAL STRUCTURE OF THE CHK1
4FT7A:CRYSTAL STRUCTURE OF THE CHK1
4FT9A:CRYSTAL STRUCTURE OF THE CHK1
4FTAA:CRYSTAL STRUCTURE OF THE CHK1
4FTCA:CRYSTAL STRUCTURE OF THE CHK1
4FTIA:CRYSTAL STRUCTURE OF THE CHK1
4FTJA:CRYSTAL STRUCTURE OF THE CHK1
4FTKA:CRYSTAL STRUCTURE OF THE CHK1
4FTLA:CRYSTAL STRUCTURE OF THE CHK1
4FTMA:CRYSTAL STRUCTURE OF THE CHK1
4FTNA:CRYSTAL STRUCTURE OF THE CHK1
4FTOA:CRYSTAL STRUCTURE OF THE CHK1
4FTQA:CRYSTAL STRUCTURE OF THE CHK1
4FTRA:CRYSTAL STRUCTURE OF THE CHK1
4FTTA:CRYSTAL STRUCTURE OF THE CHK1
4FTUA:CRYSTAL STRUCTURE OF THE CHK1
4GH2A:CRYSTAL STRUCTURE OF THE CHK1
4HYHA:X-RAY CRYSTAL STRUCTURE OF COMPOUND 39 BOUND TO HUMAN CHK1 KINASE DOMAIN
4HYIA:X-RAY CRYSTAL STRUCTURE OF COMPOUND 40 BOUND TO HUMAN CHK1 KINASE DOMAIN
4JIKA:X-RAY CRYSTAL STRUCTURE OF COMPOUND 22A (R)-2-(4-CHLOROPHENYL)-8-(PIPERIDIN-3-YLAMINO)IMIDAZO[1,2-C]PYRIMIDINE-5-CARBOXAMIDE BOUND TO HUMAN CHK1 KINASE DOMAIN
(-)
Protein domain: Cell division protein kinase 7, CDK7 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1UA2A:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN CDK7
(-)
Protein domain: Cell division protein kinase 9, CDK9 (6)
(-)
Human (Homo sapiens) [TaxId: 9606] (6)
3BLHA:8-325CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1
3LQ5A:STRUCTURE OF CDK9/CYCLINT IN COMPLEX WITH S-CR8
3MI9A:CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH HUMAN P-TEFB
3MIAA:CRYSTAL STRUCTURE OF HIV-1 TAT COMPLEXED WITH ATP-BOUND HUMAN P-TEFB
3MY1A:STRUCTURE OF CDK9/CYCLINT1 IN COMPLEX WITH DRB
3TN8A:CDK9/CYCLIN T IN COMPLEX WITH CAN508
(-)
Protein domain: Cyclin-dependent PK, CDK2 (340)
(-)
Human (Homo sapiens) [TaxId: 9606] (336)
1AQ1A:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE
1B38A:HUMAN CYCLIN-DEPENDENT KINASE 2
1B39A:HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160
1BUHA:CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1
1CKPA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B
1DI8A:THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE
1DM2A:HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE
1E1VA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058
1E1XA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027
1E9HA:; C:THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND
1F5QA:; C:CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2
1FINA:; C:CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX
1FQ1B:CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2
1FVTA:THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH AN OXINDOLE INHIBITOR
1FVVA:; C:THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR
1G5SA:CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717
1GIHA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
1GIIA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
1GIJA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
1GY3A:; C:PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE
1GZ8A:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL-2'-OXO)BUTOXYPURINE
1H00A:CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H01A:CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H07A:CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H08A:CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H0VA:HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R)-PYRROLIDINO-5'-YL]METHOXYPURINE
1H0WA:HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[CYCLOHEX-3-ENYL]METHOXYPURINE
1H1PA:; C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058
1H1QA:; C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094
1H1RA:; C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086
1H1SA:; C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102
1H24A:; C:CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F
1H25A:; C:CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN
1H26A:; C:CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53
1H27A:; C:CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27
1H28A:; C:CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107
1HCKA:HUMAN CYCLIN-DEPENDENT KINASE 2
1HCLA:HUMAN CYCLIN-DEPENDENT KINASE 2
1JSTA:; C:PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A
1JSUA:P27(KIP1)/CYCLIN A/CDK2 COMPLEX
1JSVA:THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[(6-AMINO-4-PYRIMIDINYL) AMINO]BENZENESULFONAMIDE
1JVPP:CRYSTAL STRUCTURE OF HUMAN CDK2 (UNPHOSPHORYLATED) IN COMPLEX WITH PKF049-365
1KE5A:CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
1KE6A:CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE
1KE7A:CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE
1KE8A:CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE
1KE9A:CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE
1OGUA:; C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR
1OI9A:; C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OIQA:IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
1OIRA:IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
1OITA:IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
1OIUA:; C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OIYA:; C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OKVA:; C:CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2
1OKWA:; C:CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2
1OL1A:; C:CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F-PHE)-NH2
1OL2A:; C:CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2
1P2AA:THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH A TRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR
1P5EA:; C:THE STRUCTURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (TBS)
1PF8A:CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH A NUCLEOSIDE INHIBITOR
1PKDA:; C:THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A
1PW2A:APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2
1PXIA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,5-DICHLORO-THIOPHEN-3-YL)-PYRIMIDIN-2-YLAMINE
1PXJA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINE
1PXKA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'-HYDROXYIMINOFORMAMIDE
1PXLA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL-PHENYL)-AMINE
1PXMA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 3-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL
1PXNA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL
1PXOA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-AMINO-4-METHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO-PHENYL)-AMINE
1PXPA:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE
1PYEA:CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR
1QMZA:; C:PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
1R78A:CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR
1URCA:; C:CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY
1URWA:CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B]PYRIDAZINE
1V1KA:CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1VYWA:; C:STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137
1VYZA:STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227
1W0XC:CRYSTAL STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR OLOMOUCINE.
1W8CA:CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY-8-ISOPROPYL-9H-PURIN-2-YLAMINE AND MONOMERIC CDK2
1W98A:THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E
1WCCA:SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY
1Y8YA:CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1, 5-A]PYRIMIDINE INHIBITOR
1Y91A:CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1, 5-A]PYRIMIDINE INHIBITOR
1YKRA:CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINE INHIBITOR
2A0CX:HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9-TRISUBSTITUTED PURINE CYCLIN-DEPENDENT KINASE INHIBITOR
2A4LA:HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE
2B52A:HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562
2B53A:HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325
2B54A:HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2)COMPLEXED WITH DIN-232305
2B55A:HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH INDENOPYRAXOLE DIN-101312
2BHEA:HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO-INDIRUBINE
2BHHA:HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4-HYDROXYPIPERINDINESULFONYL-INDIRUBINE
2BTRA:STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873
2BTSA:STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032
2C5NA:; C:DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5OA:; C:DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5VA:; C:DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5XA:; C:DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5YA:DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C68A:CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C69A:CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6IA:CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6KA:CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6LA:CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6MA:CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6OA:CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6TA:; C:CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2CCHA:; C:THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE
2CCIA:; C:CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6
2CJMA:; C:MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE
2CLXA:4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS
2DS1A:HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
2DUVA:STRUCTURE OF CDK2 WITH A 3-HYDROXYCHROMONES
2EXMA:HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE
2FVDA:CYCLIN DEPENDENT KINASE 2 (CDK2) WITH DIAMINOPYRIMIDINE INHIBITOR
2G9XA:; C:STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271
2I40A:; C:CDK2/CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE INHIBITOR
2IW6A:1-295; C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2IW8A:1-297STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
2IW9A:; C:STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2J9MA:CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC AMINOPYRIMIDINE
2JGZA:CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B
2R3FA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3GA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3HA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3IA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3JA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3KA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3LA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3MA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3NA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3OA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3PA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3QA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3RA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R64A:CRYSTAL STRUCTURE OF A 3-AMINOINDAZOLE COMPOUND WITH CDK2
2UUEA:; C:REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
2UZBA:; C:CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZDA:; C:CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZEA:; C:CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZLA:; C:CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZNA:CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZOA:CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2V0DA:CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2V22A:; C:REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
2VTAA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTHA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN
2VTIA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTJA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTLA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTMA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTNA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTOA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTPA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTQA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTRA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTSA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTTA:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VU3A:IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VV9A:CDK2 IN COMPLEX WITH AN IMIDAZOLE PIPERAZINE
2W05A:STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, COMPOUND 5B
2W06A:STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, COMPOUND 5C
2W17A:CDK2 IN COMPLEX WITH THE IMIDAZOLE PYRIMIDINE AMIDE, COMPOUND (S)-8B
2W1HA:FRAGMENT-BASED DISCOVERY OF THE PYRAZOL-4-YL UREA (AT9283), A MULTI-TARGETED KINASE INHIBITOR WITH POTENT AURORA KINASE ACTIVITY
2WEVA:; C:TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WFYA:; C:TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WHBA:; C:TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WMAA:; C:STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
2WMBA:; C:STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OF PEPTIDE LIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A
2X1NA:; C:TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2XMYA:DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YL) PYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS
2XNBA:DISCOVERY AND CHARACTERISATION OF 2-ANILINO-4-(THIAZOL-5-YL) PYRIMIDINE TRANSCRIPTIONAL CDK INHIBITORS AS ANTICANCER AGENTS
3BHTA:; C:STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 3
3BHUA:; C:STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 5
3BHVA:; C:STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR VARIOLIN B
3DDPA:; C:STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR CR8
3DDQA:; C:STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR ROSCOVITINE
3DOGA:; C:STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1
3EIDA:; C:CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3EZRA:CDK-2 WITH INDAZOLE INHIBITOR 17 BOUND AT ITS ACTIVE SITE
3EZVA:CDK-2 WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
3F5XA:; C:CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
3FZ1A:CRYSTAL STRUCTURE OF A BENZTHIOPHENE INHIBITOR BOUND TO HUMAN CYCLIN-DEPENDENT KINASE-2 (CDK-2)
3IG7A:NOVEL CDK-5 INHIBITORS - CRYSTAL STRUCTURE OF INHIBITOR EFP WITH CDK-2
3IGGA:NOVEL CDK-5 INHIBITORS - CRYSTAL STRUCTURE OF INHIBITOR EFQ WITH CDK-2
3LE6A:THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH A PYRAZOLOBENZODIAZEPINE INHIBITOR
3LFNA:CRYSTAL STRUCTURE OF CDK2 WITH SAR57, AN AMINOINDAZOLE TYPE INHIBITOR
3LFQA:CRYSTAL STRUCTURE OF CDK2 WITH SAR60, AN AMINOINDAZOLE TYPE INHIBITOR
3LFSA:CRYSTAL STRUCTURE OF CDK2 WITH SAR37, AN AMINOINDAZOLE TYPE INHIBITOR
3MY5A:; C:CDK2/CYCLINA IN COMPLEX WITH DRB
3NS9A:CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH INHIBITOR BS-194
3PJ8A:STRUCTURE OF CDK2 IN COMPLEX WITH A PYRAZOLO[4,3-D]PYRIMIDINE BIOISOSTERE OF ROSCOVITINE.
3PXFA:CDK2 IN COMPLEX WITH TWO MOLECULES OF 8-ANILINO-1-NAPHTHALENE SULFONATE
3PXQA:CDK2 IN COMPLEX WITH 3 MOLECULES OF 8-ANILINO-1-NAPHTHALENE SULFONATE
3PXRA:APO CDK2 CRYSTALLIZED FROM JEFFAMINE
3PXYA:CDK2 IN COMPLEX WITH INHIBITOR JWS648
3PXZA:CDK2 TERNARY COMPLEX WITH JWS648 AND ANS
3PY0A:CDK2 IN COMPLEX WITH INHIBITOR SU9516
3PY1A:CDK2 TERNARY COMPLEX WITH SU9516 AND ANS
3QHRA:; C:STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC
3QHWA:; C:STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC
3QL8A:CDK2 IN COMPLEX WITH INHIBITOR JWS-6-260
3QQFA:CDK2 IN COMPLEX WITH INHIBITOR L1
3QQGA:CDK2 IN COMPLEX WITH INHIBITOR L2-5
3QQHA:CDK2 IN COMPLEX WITH INHIBITOR L2-2
3QQJA:CDK2 IN COMPLEX WITH INHIBITOR L2
3QQKA:CDK2 IN COMPLEX WITH INHIBITOR L4
3QQLA:CDK2 IN COMPLEX WITH INHIBITOR L3
3QRTA:CDK2 IN COMPLEX WITH INHIBITOR NSK-MC2-55
3QRUA:CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-12
3QTQA:CDK2 IN COMPLEX WITH INHIBITOR RC-1-137
3QTRA:CDK2 IN COMPLEX WITH INHIBITOR RC-1-148
3QTSA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-12
3QTUA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-132
3QTWA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-13
3QTXA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-35
3QTZA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-36
3QU0A:CDK2 IN COMPLEX WITH INHIBITOR RC-2-38
3QWJA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-142
3QWKA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-150
3QX2A:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-190
3QX4A:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-78
3QXOA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-84
3QXPA:CDK2 IN COMPLEX WITH INHIBITOR RC-3-89
3QZFA:CDK2 IN COMPLEX WITH INHIBITOR JWS-6-52
3QZGA:CDK2 IN COMPLEX WITH INHIBITOR JWS-6-76
3QZHA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-124
3QZIA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-126
3R1QA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-102
3R1SA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-127
3R1YA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-134
3R28A:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-140
3R6XA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-158
3R71A:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-162
3R73A:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-164
3R7EA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-67
3R7IA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-74
3R7UA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-75
3R7VA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-9
3R7YA:CDK2 IN COMPLEX WITH INHIBITOR KVR-2-88
3R83A:CDK2 IN COMPLEX WITH INHIBITOR KVR-2-92
3R8LA:CDK2 IN COMPLEX WITH INHIBITOR L3-4
3R8MA:CDK2 IN COMPLEX WITH INHIBITOR L3-3
3R8PA:CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-6
3R8UA:CDK2 IN COMPLEX WITH INHIBITOR RC-1-132
3R8VA:CDK2 IN COMPLEX WITH INHIBITOR RC-1-135
3R8ZA:CDK2 IN COMPLEX WITH INHIBITOR RC-1-136
3R9DA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-135
3R9HA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-142
3R9NA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-21
3R9OA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-143
3RAHA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-22
3RAIA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-160
3RAKA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-32
3RALA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-34
3RJCA:CDK2 IN COMPLEX WITH INHIBITOR L4-12
3RK5A:CDK2 IN COMPLEX WITH INHIBITOR RC-2-72
3RK7A:CDK2 IN COMPLEX WITH INHIBITOR RC-2-71
3RK9A:CDK2 IN COMPLEX WITH INHIBITOR RC-2-74
3RKBA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-73
3RM6A:CDK2 IN COMPLEX WITH INHIBITOR KVR-2-80
3RM7A:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-91
3RMFA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-33
3RNIA:CDK2 IN COMPLEX WITH INHIBITOR RC-3-86
3ROYA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-154
3RPOA:CDK2 IN COMPLEX WITH INHIBITOR KVR-1-156
3RPRA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-49
3RPVA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-88
3RPYA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-40
3RZBA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-23
3S00A:CDK2 IN COMPLEX WITH INHIBITOR L4-14
3S0OA:CDK2 IN COMPLEX WITH INHIBITOR RC-1-138
3S1HA:CDK2 IN COMPLEX WITH INHIBITOR RC-2-39
3S2PA:CRYSTAL STRUCTURE OF CDK2 WITH A 2-AMINOPYRIMIDINE COMPOUND
3SQQA:CDK2 IN COMPLEX WITH INHIBITOR RC-3-96
3SW4A:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH THIAZOLYLPYRIMIDINE INHIBITOR
3SW7A:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH THIAZOLYLPYRIMIDINE INHIBITOR
3TI1A:CDK2 IN COMPLEX WITH SUNITINIB
3TIYA:CDK2 IN COMPLEX WITH NSC 35676
3TIZA:CDK2 IN COMPLEX WITH NSC 111848
3TNWA:; C:STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH CAN508
3ULIA:HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) BOUND TO AZABENZIMIDAZOLE DERIVATIVE
3UNJA:CDK2 IN COMPLEX WITH INHIBITOR YL1-038-31
3UNKA:CDK2 IN COMPLEX WITH INHIBITOR YL5-083
3WBLA:CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH PYRAZOLOPYRIMIDINE INHIBITOR
4ACMA:CDK2 IN COMPLEX WITH 3-AMINO-6-(4-{[2-(DIMETHYLAMINO)ETHYL] SULFAMOYL}-PHENYL)-N-PYRIDIN-3-YLPYRAZINE-2-CARBOXAMIDE
4BCKA:; C:STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCMA:; C:STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCNA:; C:STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCOA:; C:STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCPA:; C:STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BCQA:; C:STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR
4BGHA:CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH PAN-CDK INHIBITOR
4CFNA:; C:STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
4CFWA:; C:STRUCTURE-BASED DESIGN OF C8-SUBSTITUTED O6-CYCLOHEXYLMETHOXYGUANINE CDK1 AND 2 INHIBITORS.
4EK3A:CRYSTAL STRUCTURE OF APO CDK2
4EK4A:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH AMINOPYRAZOLE INHIBITOR
4EK5A:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH AMINOPYRAZOLE INHIBITOR
4EK6A:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH AMINOPYRAZOLE INHIBITOR
4EK8A:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH THIAZOLYLPYRIMIDINE INHIBITOR
4EOIA:; C:THR 160 PHOSPHORYLATED CDK2 K89D, Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
4EOJA:; C:THR 160 PHOSPHORYLATED CDK2 H84S, Q85M, K89D - HUMAN CYCLIN A3 COMPLEX WITH ATP
4EOKA:; C:THR 160 PHOSPHORYLATED CDK2 H84S, Q85M, K89D - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102
4EOLA:; C:THR 160 PHOSPHORYLATED CDK2 H84S, Q85M, K89D - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
4EOMA:; C:THR 160 PHOSPHORYLATED CDK2 H84S, Q85M, Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP
4EONA:; C:THR 160 PHOSPHORYLATED CDK2 H84S, Q85M, Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
4EOOA:; C:THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH ATP
4EOPA:; C:THR 160 PHOSPHORYLATED CDK2 Q131E - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
4EOQA:; C:THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH ATP
4EORA:; C:THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR NU6102
4EOSA:; C:THR 160 PHOSPHORYLATED CDK2 WT - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR RO3306
4ERWA:CDK2 IN COMPLEX WITH STAUROSPORINE
4EZ3A:CDK2 IN COMPLEX WITH NSC 134199
4EZ7A:CDK2 IN COMPLEX WITH STAUROSPORINE AND 2 MOLECULES OF 8-ANILINO-1-NAPHTHALENE SULFONIC ACID
4FKGA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH AMINOPYRAZOLE INHIBITOR
4FKIA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH AMINOPYRAZOLE INHIBITOR
4FKJA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH AMINOPYRAZOLE INHIBITOR
4FKLA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH THIAZOLYLPYRIMIDINE INHIBITOR
4FKOA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH THIAZOLYLPYRIMIDINE INHIBITOR
4FKPA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH OXINDOLE INHIBITOR
4FKQA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH OXINDOLE INHIBITOR
4FKRA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH OXINDOLE INHIBITOR
4FKSA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH OXINDOLE INHIBITOR
4FKTA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH OXINDOLE INHIBITOR
4FKUA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH OXINDOLE INHIBITOR
4FKVA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH OXINDOLE INHIBITOR
4FKWA:CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH OXINDOLE INHIBITOR
4FX3A:; C:CRYSTAL STRUCTURE OF THE CDK2/CYCLIN A COMPLEX WITH OXINDOLE INHIBITOR
4GCJA:CDK2 IN COMPLEX WITH INHIBITOR RC-3-89
4I3ZA:; C:STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS
4II5A:; C:STRUCTURE OF PCDK2/CYCLINA BOUND TO ADP AND 1 MAGNESIUM ION
4KD1A:CDK2 IN COMPLEX WITH DINACICLIB
4LYNA:CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2-WT) COMPLEX WITH (2S)-N-(5-(((5-TERT-BUTYL-1,3-OXAZOL-2-YL)METHYL)SULFANYL)-1,3-THIAZOL-2-YL)-2-PHENYLPROPANAMIDE
4NJ3A:MODULATING THE INTERACTION BETWEEN CDK2 AND CYCLIN A WITH A QUINOLINE-BASED INHIBITOR
(-)
Malaria parasite (Plasmodium falciparum) [TaxId: 5833] (4)
1OB3A:; B:STRUCTURE OF P. FALCIPARUM PFPK5
1V0BA:; B:CRYSTAL STRUCTURE OF THE T198A MUTANT OF PFPK5
1V0OA:; B:STRUCTURE OF P. FALCIPARUM PFPK5-INDIRUBIN-5-SULPHONATE LIGAND COMPLEX
1V0PA:; B:STRUCTURE OF P. FALCIPARUM PFPK5-PURVALANOL B LIGAND COMPLEX
(-)
Protein domain: Cyclin-dependent PK, CDK5 (5)
(-)
Human (Homo sapiens) [TaxId: 9606] (5)
1H4LA:; B:STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX
1UNGA:; B:STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.
1UNHA:; B:STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.
1UNLA:; B:STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE, ALOISINE AND INDIRUBIN.
3O0GA:; B:CRYSTAL STRUCTURE OF CDK5:P25 IN COMPLEX WITH AN ATP ANALOGUE
(-)
Protein domain: Cyclin-dependent PK, CDK6 (11)
(-)
Human (Homo sapiens) [TaxId: 9606] (11)
1BI7A:MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURE OF THE CDK6-P16INK4A TUMOR SUPPRESSOR COMPLEX
1BI8A:; C:MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURES CDK6-P19INK4D INHIBITOR COMPLEX
1BLXA:P19INK4D/CDK6 COMPLEX
1G3NA:; E:STRUCTURE OF A P18(INK4C)-CDK6-K-CYCLIN TERNARY COMPLEX
1JOWB:CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN CDK6 AND A VIRAL CYCLIN
1XO2B:CRYSTAL STRUCTURE OF A HUMAN CYCLIN-DEPENDENT KINASE 6 COMPLEX WITH A FLAVONOL INHIBITOR, FISETIN
2EUFB:X-RAY STRUCTURE OF HUMAN CDK6-VCYCLIN IN COMPLEX WITH THE INHIBITOR PD0332991
2F2CB:X-RAY STRUCTURE OF HUMAN CDK6-VCYCLINWITH THE INHIBITOR AMINOPURVALANOL
3NUPA:CDK6 (MONOMERIC) IN COMPLEX WITH INHIBITOR
3NUXA:CDK6 (MONOMERIC) IN COMPLEX WITH INHIBITOR
4AUAA:LIGANDED X-RAY CRYSTAL STRUCTURE OF CYCLIN DEPENDENT KINASE 6 (CDK6)
(-)
Protein domain: Death-associated protein kinase, Dap (6)
(-)
Human (Homo sapiens) [TaxId: 9606] (6)
1IG1A:1.8A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MN.
1JKKA:2.4A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MG.
1JKLA:1.6A X-RAY STRUCTURE OF BINARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE
1JKSA:1.5A X-RAY STRUCTURE OF APO FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
1JKTA:; B:TETRAGONAL CRYSTAL FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
1P4FA:DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH BOUND INHIBITOR FRAGMENT
(-)
Protein domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 (16)
(-)
Human (Homo sapiens) [TaxId: 9606] (16)
1S9JA:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
2P55A:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
3DV3A:MEK1 WITH PF-04622664 BOUND
3DY7A:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
3E8NA:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) COMPLEXED WITH A POTENT INHIBITOR RDEA119 AND MGATP
3EQBA:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
3EQCA:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A TERNARY COMPLEX WITH COMPOUND 1, ATP-GS AND MG2P
3EQDA:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A BINARY COMPLEX WITH ATP-GS AND MG2P
3EQFA:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A BINARY COMPLEX WITH K252A AND MG2P
3EQGA:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A TERNARY COMPLEX WITH PD, ADP AND MG2P
3EQHA:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A TERNARY COMPLEX WITH U0126, ADP AND MG2P
3EQIA:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A BINARY COMPLEX WITH ADP AND MG2P
3V01A:DISCOVERY OF NOVEL ALLOSTERIC MEK INHIBITORS POSSESSING CLASSICAL AND NON-CLASSICAL BIDENTATE SER212 INTERACTIONS.
3V04A:DISCOVERY OF NOVEL ALLOSTERIC MEK INHIBITORS POSSESSING CLASSICAL AND NON-CLASSICAL BIDENTATE SER212 INTERACTIONS.
3VVHA:; B:; C:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN COMPLEX WITH AN INHIBITOR AND MGATP
4LMNA:CRYSTAL STRUCTURE OF MEK1 KINASE BOUND TO GDC0973
(-)
Protein domain: Dual specificity mitogen-activated protein kinase kinase 2, Mek2 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1S9IA:; B:X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (MEK2)IN A COMPLEX WITH LIGAND AND MGATP
(-)
Protein domain: EGF receptor tyrosine kinase, Erbb-1 (36)
(-)
Human (Homo sapiens) [TaxId: 9606] (36)
1M14A:TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR
1M17A:EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN WITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB
1XKKA:EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR-GW572016
2EB2A:CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (G719S)
2EB3A:CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (L858R) IN COMPLEX WITH AMPPNP
2GS2A:CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN
2GS6A:CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AN ATP ANALOG-PEPTIDE CONJUGATE
2GS7A:; B:CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
2ITYA:697-1018CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH IRESSA
2RFED:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
2RGPA:STRUCTURE OF EGFR IN COMPLEX WITH HYDRAZONE, A POTENT DUAL INHIBITOR
3BELA:X-RAY STRUCTURE OF EGFR IN COMPLEX WITH OXIME INHIBITOR
3GT8A:; B:; C:; D:CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
3IKAA:; B:CRYSTAL STRUCTURE OF EGFR 696-1022 T790M MUTANT COVALENTLY BINDING TO WZ4002
3POZA:EGFR KINASE DOMAIN COMPLEXED WITH TAK-285
3UG1A:CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN THE APO FORM
3UG2A:CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN COMPLEX WITH GEFITINIB
3VJNA:CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN COMPLEX WITH AMPPNP.
3VJOA:CRYSTAL STRUCTURE OF THE WILD-TYPE EGFR KINASE DOMAIN IN COMPLEX WITH AMPPNP.
3W2OA:EGFR KINASE DOMAIN T790M/L858R MUTANT WITH TAK-285
3W2PA:EGFR KINASE DOMAIN T790M/L858R MUTANT WITH COMPOUND 2
3W2QA:EGFR KINASE DOMAIN T790M/L858R MUTANT WITH HKI-272
3W2RA:EGFR KINASE DOMAIN T790M/L858R MUTANT WITH COMPOUND 4
3W2SA:EGFR KINASE DOMAIN WITH COMPOUND4
3W32A:EGFR KINASE DOMAIN COMPLEXED WITH COMPOUND 20A
3W33A:EGFR KINASE DOMAIN COMPLEXED WITH COMPOUND 19B
4HJOA:CRYSTAL STRUCTURE OF THE INACTIVE EGFR TYROSINE KINASE DOMAIN WITH ERLOTINIB
4I22A:STRUCTURE OF THE MONOMERIC (V948R)GEFITINIB/ERLOTINIB RESISTANT DOUBLE MUTANT (L858R+T790M) EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH GEFITINIB
4I23A:CRYSTAL STRUCTURE OF THE WILD-TYPE EGFR KINASE DOMAIN IN COMPLEX WITH DACOMITINIB (SOAKED)
4I24A:; B:STRUCTURE OF T790M EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH DACOMITINIB
4JQ7A:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 2A
4JQ8A:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 4B
4JR3A:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 3G
4JRVA:CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 4C
4LI5A:EGFR-K IN COMPLEX WITH N-[3-[[5-CHLORO-4-(1H-INDOL-3-YL)PYRIMIDIN-2-YL]AMINO]-4-METHOXY-PHENYL] PROP-2-ENAMIDE
4LQMA:EGFR L858R IN COMPLEX WITH PD168393
(-)
Protein domain: epha2 receptor tyrosine kinase (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1MQBA:; B:CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
(-)
Protein domain: ephb2 receptor tyrosine kinase (1)
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1JPAA:; B:CRYSTAL STRUCTURE OF UNPHOSPHORYLATED EPHB2 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
(-)
Protein domain: Fibroblast growth factor receptor 1 (15)
(-)
Human (Homo sapiens) [TaxId: 9606] (15)
1AGWA:; B:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR
1FGIA:; B:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU5402 INHIBITOR
1FGKA:; B:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1
2FGIA:; B:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074
3C4FA:; B:FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-METHOXYBENZYL)-7-AZAINDOLE
3JS2A:; B:CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID
3KY2A:; B:CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN
3RHXA:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR1 KINASE IN COMPLEX WITH ARQ 069
3TT0A:; B:CO-STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN WITH 3-(2,6-DICHLORO-3,5-DIMETHOXY-PHENYL)-1-{6-[4-(4-ETHYL-PIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA (BGJ398)
4F63A:; B:CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 1
4F64A:; B:CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 6
4F65A:; B:CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH COMPOUND 8
4NK9A:; B:CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 1
4NKAA:; B:CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 2
4NKSA:; B:CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 3
(-)
Protein domain: Fibroblast growth factor receptor 2 (16)
(-)
Human (Homo sapiens) [TaxId: 9606] (16)
1GJOA:THE FGFR2 TYROSINE KINASE DOMAIN
1OECA:FGFR2 KINASE DOMAIN
2PSQA:; B:CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN
2PVFA:CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND SUBSTRATE PEPTIDE
2PVYA:; B:; C:; D:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
2PWLA:; B:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME.
2PY3A:; B:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2PZ5A:; B:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2PZPA:; B:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME
2PZRA:; B:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2Q0BA:; B:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
4J95A:; B:; C:; D:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME IN SPACE GROUP C2.
4J96A:; B:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659M MUTATION IDENTIFIED IN CERVICAL CANCER.
4J97A:; B:; C:; D:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC GAIN-OF-FUNCTION K659E MUTATION IDENTIFIED IN ENDOMETRIAL CANCER.
4J98A:; B:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659Q MUTATION.
4J99A:; B:; C:; D:CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE GAIN-OF-FUNCTION K659T MUTATION.
(-)
Protein domain: Fl cytokine receptor (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1RJBA:CRYSTAL STRUCTURE OF FLT3
(-)
Protein domain: Focal adhesion kinase 1 (fak) (16)
(-)
Chicken (Gallus gallus) [TaxId: 9031] (2)
2J0MB:CRYSTAL STRUCTURE A TWO-CHAIN COMPLEX BETWEEN THE FERM AND KINASE DOMAINS OF FOCAL ADHESION KINASE.
2JKQA:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR
(-)
Human (Homo sapiens) [TaxId: 9606] (14)
1MP8A:CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE (FAK)
2ETMA:; B:CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN COMPLEXED WITH 7H-PYRROLO [2,3-D] PYRIMIDINE DERIVATIVE
2IJMA:; B:CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN WITH 2 MOLECULES IN THE ASYMMETRIC UNIT COMPLEXED WITH ADP AND ATP
3BZ3A:CRYSTAL STRUCTURE ANALYSIS OF FOCAL ADHESION KINASE WITH A METHANESULFONAMIDE DIAMINOPYRIMIDINE INHIBITOR
4EBVA:STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH NOVEL ALLOSTERIC INHIBITOR
4EBWA:STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH NOVEL ALLOSTERIC INHIBITOR
4GU6A:; B:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH N-{3-[(5-CYANO-2-PHENYL-1H-PYRROLO[2,3-B]PYRIDIN-4-YLAMINO)- METHYL]-PYRIDIN-2-YL}-N-METHYL-METHANESULFONAMIDE
4GU9A:; B:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH (2-FLUORO-PHENYL)-(1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YL)-AMINE
4I4EA:STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH HINGE BINDING PYRAZOLOBENZOTHIAZINE COMPOUND.
4I4FA:STRUCTURE OF FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH AN ALLOSTERIC BINDING PYRAZOLOBENZOTHIAZINE COMPOUND.
4K8AA:; B:FRAGMENT-BASED DISCOVERY OF FOCAL ADHESION KINASE INHIBITORS
4K9YA:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-[4-(6-AMINO-PURIN-9-YL)-PHENYL]-3-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-UREA
4KABA:; B:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 3-METHYL-1,4-DIHYDRO-PYRAZOLO[4,5-C]PYRAZOLE
4KAOA:; B:FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-(4-PYRIDIN-3- YL-PHENYL)-UREA
(-)
Protein domain: G-protein coupled receptor kinase 2 (6)
(-)
Cow (Bos taurus) [TaxId: 9913] (6)
1OMWA:186-549CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN G PROTEIN-COUPLED RECEPTOR KINASE 2 AND HETEROTRIMERIC G PROTEIN BETA 1 AND GAMMA 2 SUBUNITS
1YM7A:186-549; B:186-549; C:186-549; D:186-542G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)
2BCJA:186-549CRYSTAL STRUCTURE OF G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH GALPHA-Q AND GBETAGAMMA SUBUNITS
3PSCA:186-549BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
3PVUA:186-549BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND A SELECTIVE KINASE INHIBITOR (CMPD101)
3PVWA:186-549BOVINE GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS AND A SELECTIVE KINASE INHIBITOR (CMPD103A)
(-)
Protein domain: gamma-subunit of glycogen phosphorylase kinase (Phk) (3)
(-)
Rabbit (Oryctolagus cuniculus) [TaxId: 9986] (3)
1PHKA:TWO STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHORYLASE, KINASE: AN ACTIVE PROTEIN KINASE COMPLEXED WITH NUCLEOTIDE, SUBSTRATE-ANALOGUE AND PRODUCT
1QL6A:THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES
2PHKA:THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION
(-)
Protein domain: Glycogen synthase kinase-3 beta (Gsk3b) (35)
(-)
Human (Homo sapiens) [TaxId: 9606] (35)
1GNGA:; B:GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE
1H8FA:; B:GLYCOGEN SYNTHASE KINASE 3 BETA.
1I09A:; B:STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B)
1J1BA:; B:BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH AMPPNP
1J1CA:; B:BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH ADP
1O9UA:GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE
1PYXA:; B:GSK-3 BETA COMPLEXED WITH AMP-PNP
1Q3DA:; B:GSK-3 BETA COMPLEXED WITH STAUROSPORINE
1Q3WA:; B:GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE
1Q41A:; B:GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'-MONOXIME
1Q4LA:; B:GSK-3 BETA COMPLEXED WITH INHIBITOR I-5
1Q5KA:; B:CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 IN COMPLEXED WITH INHIBITOR
1R0EA:; B:GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4-ARYLMALEIMIDE INHIBITOR
1UV5A:GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'-OXIME
2JLDA:; B:EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE KINASE 3
2O5KA:35-384CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A BENZOIMIDAZOL INHIBITOR
2OW3A:; B:GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH BIS-(INDOLE)MALEIMIDE PYRIDINOPHANE INHIBITOR
3DU8A:; B:CRYSTAL STRUCTURE OF GSK-3 BETA IN COMPLEX WITH NMS-869553A
3F7ZA:; B:X-RAY CO-CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3BETA IN COMPLEX WITH AN INHIBITOR
3F88A:; B:GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR COMPLEX
3I4BA:; B:CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH A PYRIMIDYLPYRROLE INHIBITOR
3L1SA:; B:3-ARYL-4-(ARYLHYDRAZONO)-1H-PYRAZOL-5-ONES: HIGHLY LIGAND EFFICIENT AND POTENT INHIBITORS OF GSK3
3M1SA:; B:STRUCTURE OF RUTHENIUM HALF-SANDWICH COMPLEX BOUND TO GLYCOGEN SYNTHASE KINASE 3
3PUPA:; B:STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA (GSK3B) IN COMPLEX WITH A RUTHENIUM OCTASPORINE LIGAND (OS1)
3Q3BA:; B:6-AMINO-4-(PYRIMIDIN-4-YL)PYRIDONES: NOVEL GLYCOGEN SYNTHASE KINASE-3 INHIBITORS
3SAYA:; B:CRYSTAL STRUCTURE OF HUMAN GLYCOGEN SYNTHASE KINASE 3 BETA (GSK3B) IN COMPLEX WITH INHIBITOR 142
3SD0A:; B:IDENTIFICATION OF A GLYCOGEN SYNTHASE KINASE-3B INHIBITOR THAT ATTENUATES HYPERACTIVITY IN CLOCK MUTANT MICE
3ZRKA:; B:IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
3ZRLA:; B:IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
3ZRMA:; B:IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS
4DITA:CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A IMIDAZOPYRIDINE INHIBITOR
4IQ6A:; B:GSK-3BETA WITH INHIBITOR 6-CHLORO-N-CYCLOHEXYL-4-(1H-PYRROLO[2,3-B]PYRIDIN-3-YL)PYRIDIN-2-AMINE
4J1RA:; B:; C:; D:CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 15R
4J71A:; B:CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH INHIBITOR 1R
4NM0A:CRYSTAL STRUCTURE OF PEPTIDE INHIBITOR-FREE GSK-3/AXIN COMPLEX
(-)
Protein domain: Haemopoetic cell kinase Hck (19)
(-)
Human (Homo sapiens) [TaxId: 9606] (19)
1AD5A:249-531; B:249-531SRC FAMILY KINASE HCK-AMP-PNP COMPLEX
1QCFA:249-531CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITOR
2C0IA:224-505; B:224-505SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983
2C0OA:224-505; B:224-505SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041
2C0TA:224-505; B:224-505SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359
2HCKA:249-531; B:249-531SRC FAMILY KINASE HCK-QUERCETIN COMPLEX
2HK5A:HCK KINASE IN COMPLEX WITH LCK TARGETTED INHIBITOR PG-1009247
3VRYA:250-531; B:250-531CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 4-AMINO-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL-CYCLOPENTANE
3VRZA:250-531; B:250-531CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)PHENYL]-3-BENZYLUREA
3VS0A:250-531; B:250-531CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR N-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL) PHENYL]BENZAMIDE
3VS1A:250-531; B:250-531CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 1-[4-(4-AMINO-7-CYCLOPENTYL-7H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)PHENYL]-3-PHENYLUREA
3VS2A:250-531; B:250-531CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[CIS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
3VS3A:250-531; B:250-531CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
3VS4A:250-531; B:250-531CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 5-(4-PHENOXYPHENYL)-7-(TETRAHYDRO-2H-PYRAN-4-YL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
3VS5A:250-531; B:250-531CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE INHIBITOR 7-(1-METHYLPIPERIDIN-4-YL)-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
3VS6A:250-531; B:250-531CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR TERT-BUTYL {4-[4-AMINO-1-(PROPAN-2-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]-2-METHOXYPHENYL}CARBAMATE
3VS7A:250-531; B:250-531CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDINE INHIBITOR 1-CYCLOPENTYL-3-(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE
4LUDA:250-531; B:250-529CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002
4LUEA:250-530; B:250-530CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4-METHYLPIPERAZIN-1-YL)CYCLOHEXYL]-5-(4-PHENOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE (RESULTING FROM DISPLACEMENT OF SKF86002)
(-)
Protein domain: Hepatocyte growth factor receptor, c-MET (34)
(-)
Human (Homo sapiens) [TaxId: 9606] (34)
1R0PA:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH THE MICROBIAL ALKALOID K-252A
1R1WA:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET
2RFNA:; B:X-RAY STRUCTURE OF C-MET WITH INHIBITOR.
2RFSA:X-RAY STRUCTURE OF SU11274 BOUND TO C-MET
2WD1A:HUMAN C-MET KINASE IN COMPLEX WITH AZAINDOLE INHIBITOR
3C1XA:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOTRIAZINE BASED INHIBITOR
3CCNA:X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR.
3CD8A:X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR.
3CE3A:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOPYRIDINEPYRIDONE BASED INHIBITOR
3CTHA:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR
3CTJA:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR
3DKCA:STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH ATP
3DKFA:STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523
3DKGA:STRUCTURE OF MUTANT(Y1248L) MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523
3EFJA:; B:STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 7
3EFKA:; B:STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 50
3F66A:; B:HUMAN C-MET KINASE IN COMPLEX WITH QUINOXALINE INHIBITOR
3F82A:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH N-(4-(2-AMINO-3-CHLOROPYRIDIN-4-YLOXY)-3-FLUOROPHENYL)-4-ETHOXY-1-(4-FLUOROPHENYL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE
3I5NA:CRYSTAL STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR 13
3L8VA:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A BIARYLAMINE BASED INHIBITOR
3LQ8A:STRUCTURE OF THE KINASE DOMAIN OF C-MET BOUND TO XL880 (GSK1363089)
3Q6UA:STRUCTURE OF THE APO MET RECEPTOR KINASE IN THE DUALLY-PHOSPHORYLATED, ACTIVATED STATE
3Q6WA:STRUCTURE OF DUALLY-PHOSPHORYLATED MET RECEPTOR KINASE IN COMPLEX WITH AN MK-2461 ANALOG WITH SPECIFICITY FOR THE ACTIVATED RECEPTOR
3QTIA:; B:C-MET KINASE IN COMPLEX WITH NVP-BVU972
3R7OA:STRUCTURE OF DUALLY PHOSPHORYLATED C-MET RECEPTOR KINASE IN COMPLEX WITH AN MK-2461 ANALOG
3RHKA:; B:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF C-MET KINASE IN COMPLEX WITH ARQ 197
3U6HA:CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH PYRAZOLONE INHIBITOR 26
3U6IA:CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH PYRAZOLONE INHIBITOR 58A
3VW8A:CRYSTAL STRUCTURE OF HUMAN C-MET KINASE DOMAIN WITH ITS INHIBITOR
4DEGA:CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH TRIAZOLOPYRIDAZINE INHIBITOR 2
4DEHA:CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH TRIAZOLOPYRIDINONE INHIBITOR 3
4DEIA:CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH TRIAZOLOPYRIDINONE INHIBITOR 24
4EEVA:CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH LY2801653
4IWDA:STRUCTURE OF DUALLY PHOSPHORYLATED C-MET RECEPTOR KINASE IN COMPLEX WITH AN MK-8033 ANALOG
(-)
Protein domain: Insulin receptor (16)
(-)
Human (Homo sapiens) [TaxId: 9606] (16)
1GAGA:CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR
1I44A:CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
1IR3A:PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG
1IRKA:CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN RECEPTOR
1P14A:CRYSTAL STRUCTURE OF A CATALYTIC-LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
1RQQA:; B:CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS
2AUHA:987-1283CRYSTAL STRUCTURE OF THE GRB14 BPS REGION IN COMPLEX WITH THE INSULIN RECEPTOR TYROSINE KINASE
2B4SB:; D:CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
2Z8CA:984-1283PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN-2-YL]AMINO}PHENYL)ACETIC ACID
3BU3A:CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE
3BU5A:CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE AND ATP
3BU6A:CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PHOSPHOPEPTIDE
3EKKA:INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR
3EKNA:INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR
3ETAA:; B:KINASE DOMAIN OF INSULIN RECEPTOR COMPLEXED WITH A PYRROLO PYRIDINE INHIBITOR
4IBMA:; B:CRYSTAL STRUCTURE OF INSULIN RECEPTOR KINASE DOMAIN IN COMPLEX WITH AN INHIBITOR IRFIN-1
(-)
Protein domain: Insulin-like growth factor 1 receptor (16)
(-)
Human (Homo sapiens) [TaxId: 9606] (16)
1JQHA:; B:; C:IGF-1 RECEPTOR KINASE DOMAIN
1K3AA:STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE
1M7NA:; B:CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN
1P4OA:; B:STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION.
2OJ9A:STRUCTURE OF IGF-1R KINASE DOMAIN COMPLEXED WITH A BENZIMIDAZOLE INHIBITOR
2ZM3A:; B:; C:; D:COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
3D94A:CRYSTAL STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE IN COMPLEX WITH PQIP
3F5PA:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:; M:; R:; S:; T:COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3-CYANOQUINOLINE INHIBITOR
3I81A:CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH BMS-754807 [1-(4-((5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO)PYRROLO[2,1-F][1,2,4]TRIAZIN-2-YL)-N-(6-FLUORO-3-PYRIDINYL)-2-METHYL-L-PROLINAMIDE]
3LVPA:; B:; C:; D:CRYSTAL STRUCTURE OF BISPHOSPHORYLATED IGF1-R KINASE DOMAIN (2P) IN COMPLEX WITH A BIS-AZAINDOLE INHIBITOR
3LW0A:; B:; C:; D:IGF-1RK IN COMPLEX WITH LIGAND MSC1609119A-1
3NW5A:CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (11B)
3NW6A:CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (11A)
3NW7A:CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH A CARBON-LINKED PROLINE ISOSTERE INHIBITOR (34)
3O23A:HUMAN UNPHOSPHORYLATED IGF1-R KINASE DOMAIN IN COMPLEX WITH AN HYDANTOIN INHIBITOR
3QQUA:; B:; C:; D:COCRYSTAL STRUCTURE OF UNPHOSPHORYLATED IGF WITH PYRIMIDINE 8
(-)
Protein domain: Lymphocyte kinase (lck) (34)
(-)
Human (Homo sapiens) [TaxId: 9606] (34)
1QPCA:STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPDA:STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPEA:STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPJA:CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE.
2OF2A:CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 8 BOUND TO LCK
2OF4A:CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 1 BOUND TO LCK
2OFUA:X-RAY CRYSTAL STRUCTURE OF 2-AMINOPYRIMIDINE CARBAMATE 43 BOUND TO LCK
2OFVA:; B:CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK
2OG8A:; B:CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK
2PL0A:LCK BOUND TO IMATINIB
2ZM1A:CRYSTAL STRUCTURE OF IMIDAZO PYRAZIN 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
2ZM4A:CRYSTAL STRUCTURE OF IMIDAZO QUINOXALINE 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
2ZYBA:CRYSTAL STRUCTURE OF PHENYLIMIDAZO PYRAZIN 2 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC1A:CRYSTAL STRUCTURE OF PYRAZIN DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC2A:CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC3A:CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC4A:CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC5A:CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC8A:CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3ACJA:CRYSTAL STRUCTURE OF IMIDAZO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3ACKA:CRYSTAL STRUCTURE OF PYRROLO PYRAZINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AD4A:CRYSTAL STRUCTURE OF METHOXY BENZOFURAN DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AD5A:CRYSTAL STRUCTURE OF TRIAZOLONE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AD6A:CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3B2WA:CRYSTAL STRUCTURE OF PYRIMIDINE AMIDE 11 BOUND TO LCK
3BYMA:X-RAY CO-CRYSTAL STRUCTURE AMINOBENZIMIDAZOLE TRIAZINE 1 BOUND TO LCK
3BYOA:X-RAY CO-CRYSTAL STRUCTURE OF 2-AMINO-6-PHENYLPYRIMIDO[5', 4':5,6]PYRIMIDO[1,2-A]BENZIMIDAZOL-5(6H)-ONE 25 BOUND TO LCK
3BYSA:CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE AMIDE 10B
3BYUA:CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE REVERSE AMIDE 23
3KMMA:STRUCTURE OF HUMAN LCK KINASE WITH A SMALL MOLECULE INHIBITOR
3KXZA:THE COMPLEX CRYSTAL STRUCTURE OF LCK WITH A PROBE MOLECULE W259
3LCKA:THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
3MPMA:LCK COMPLEXED WITH A PYRAZOLOPYRIMIDINE
4C3FA:STRUCTURE OF LCK IN COMPLEX WITH A COMPOUND DISCOVERED BY VIRTUAL FRAGMENT LINKING
(-)
Protein domain: MAP kinase activated protein kinase 2, mapkap2 (14)
(-)
Human (Homo sapiens) [TaxId: 9606] (14)
1KWPA:; B:CRYSTAL STRUCTURE OF MAPKAP2
1NXKA:; B:; C:; D:CRYSTAL STRUCTURE OF STAUROSPORINE BOUND TO MAP KAP KINASE 2
1NY3A:CRYSTAL STRUCTURE OF ADP BOUND TO MAP KAP KINASE 2
2ONLC:46-385; D:46-385CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER
2OZAA:STRUCTURE OF P38ALPHA COMPLEX
2PZYA:; B:; C:; D:STRUCTURE OF MK2 COMPLEXED WITH COMPOUND 76
3KA0A:MK2 COMPLEX WITH INHIBITOR 6-(5-(2-AMINOPYRIMIDIN-4-YLAMINO)-2-HYDROXYPHENYL)-N-METHYLBENZO[B]THIOPHENE-2-CARBOXAMIDE
3KC3A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE
3KGAA:CRYSTAL STRUCTURE OF MAPKAP KINASE 2 (MK2) COMPLEXED WITH A POTENT 3-AMINOPYRAZOLE ATP SITE INHIBITOR
3M2WA:CRYSTAL STRUCTURE OF MAPKAK KINASE 2 (MK2) COMPLEXED WITH A SPIROAZETIDINE-TETRACYCLIC ATP SITE INHIBITOR
3M42A:CRYSTAL STRUCTURE OF MAPKAP KINASE 2 (MK2) COMPLEXED WITH A TETRACYCLIC ATP SITE INHIBITOR
3R2BA:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:MK2 KINASE BOUND TO COMPOUND 5B
3R2YA:MK2 KINASE BOUND TO COMPOUND 1
3WI6A:; B:; C:; D:; E:; F:CRYSTAL STRUCTURE OF MAPKAP KINASE-2 (MK2) IN COMPLEX WITH NON-SELECTIVE INHIBITOR
(-)
Protein domain: MAP kinase Erk2 (18)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1PMEA:STRUCTURE OF PENTA MUTANT HUMAN ERK2 MAP KINASE COMPLEXED WITH A SPECIFIC INHIBITOR OF HUMAN P38 MAP KINASE
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (17)
1ERKA:STRUCTURE OF SIGNAL-REGULATED KINASE
1GOLA:COORDINATES OF RAT MAP KINASE ERK2 WITH AN ARGININE MUTATION AT POSITION 52
2ERKA:PHOSPHORYLATED MAP KINASE ERK2
2FYSA:; B:CRYSTAL STRUCTURE OF ERK2 COMPLEX WITH KIM PEPTIDE DERIVED FROM MKP3
2GPHA:DOCKING MOTIF INTERACTIONS IN THE MAP KINASE ERK2
2Z7LA:UNPHOSPHORYLATED MITOGEN ACTIVATED PROTEIN KINASE ERK2 IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN 2-YL]AMINO}PHENYL)ACETIC ACID
3C9WA:; B:CRYSTAL STRUCTURE OF ERK-2 WITH HYPOTHEMYCIN COVALENTLY BOUND
3ERKA:THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/SB220025
3O71A:CRYSTAL STRUCTURE OF ERK2/DCC PEPTIDE COMPLEX
3QYWA:CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
3QYZA:CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH AN INHIBITOR
3R63A:STRUCTURE OF ERK2 (SPE) MUTANT (S246E)
4ERKA:THE COMPLEX STRUCTURE OF THE MAP KINASE ERK2/OLOMOUCINE
4GSBA:MONOCLINIC CRYSTAL FORM OF THE APO-ERK2
4GT3A:ATP-BOUND FORM OF THE ERK2 KINASE
4GVAA:ADP-BOUND FORM OF THE ERK2 KINASE
(-)
Protein domain: MAP kinase p38 (184)
(-)
Human (Homo sapiens) [TaxId: 9606] (162)
1A9UA:THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580
1BL6A:THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995
1BL7A:THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025
1BMKA:THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655
1DI9A:THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7-DIMETHOXYQUINAZOLINE
1IANA:HUMAN P38 MAP KINASE INHIBITOR COMPLEX
1KV1A:P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1
1KV2A:HUMAN P38 MAP KINASE IN COMPLEX WITH BIRB 796
1M7QA:CRYSTAL STRUCTURE OF P38 MAP KINASE IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR
1OUKA:THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A PYRIDINYLIMIDAZOLE INHIBITOR
1OUYA:THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROPYRIDO-PYRIMIDINE INHIBITOR
1OVEA:THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROQUINOLINONE
1OZ1A:P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR
1R39A:THE STRUCTURE OF P38ALPHA
1R3CA:THE STRUCTURE OF P38ALPHA C162S MUTANT
1WFCA:STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN
1YQJA:CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH A SELECTIVE PYRIDAZINE INHIBITOR
1ZYJA:HUMAN P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1A
1ZZ2A:TWO CLASSES OF P38ALPHA MAP KINASE INHIBITORS HAVING A COMMON DIPHENYLETHER CORE BUT EXHIBITING DIVERGENT BINDING MODES
1ZZLA:CRYSTAL STRUCTURE OF P38 WITH TRIAZOLOPYRIDINE
2BAJA:P38ALPHA BOUND TO PYRAZOLOUREA
2BAKA:P38ALPHA MAP KINASE BOUND TO MPAQ
2BALA:P38ALPHA MAP KINASE BOUND TO PYRAZOLOAMINE
2BAQA:P38ALPHA BOUND TO RO3201195
2GFSA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO3201195
2I0HA:THE STRUCTURE OF P38ALPHA IN COMPLEX WITH AN ARYLPYRIDAZINONE
2LGCA:JOINT NMR AND X-RAY REFINEMENT REVEALS THE STRUCTURE OF A NOVEL DIBENZO[A,D]CYCLOHEPTENONE INHIBITOR/P38 MAP KINASE COMPLEX IN SOLUTION
2OKRA:; D:CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER
2ONLA:4-352; B:4-352CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER
2QD9A:P38 ALPHA MAP KINASE INHIBITOR BASED ON HETEROBICYCLIC SCAFFOLDS
2RG5A:PHENYLALANINE PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 11B
2RG6A:PHENYLALANINE PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 11J
3BV2A:MORPHOLINO PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 30
3BV3A:MORPHOLINO PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 2
3BX5A:P38 ALPHA MAP KINASE COMPLEXED WITH BMS-640994
3C5UA:P38 ALPHA MAP KINASE COMPLEXED WITH A BENZOTHIAZOLE BASED INHIBITOR
3CTQA:STRUCTURE OF MAP KINASE P38 IN COMPLEX WITH A 1-O-TOLYL-1,2, 3-TRIAZOLE-4-CARBOXAMIDE
3D7ZA:CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE INHIBITOR
3D83A:CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE INHIBITOR
3DS6A:; B:; C:; D:P38 COMPLEX WITH A PHTHALAZINE INHIBITOR
3DT1A:P38 COMPLEXED WITH A QUINAZOLINE INHIBITOR
3FC1X:CRYSTAL STRUCTURE OF P38 KINASE BOUND TO PYRIMIDO-PYRIDAZINONE INHIBITOR
3FI4A:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO4499
3FKLA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO9552
3FKNA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO7125
3FKOA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO3668
3FL4A:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO5634
3FLNC:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH R1487
3FLQA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-((S)-2-METHANESULFONYL-1-METHYL-ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN
3FLSA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-((R)-2-METHANESULFONYL-1-METHYL-ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FLWA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH PAMAPIMOD
3FLYA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-ISOPROPYLAMINO-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FLZA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 8-METHYL-6-PHENOXY-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FMHA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-8-METHYL-2-((R)-1-METHYL-2-TETRAZOL-2-YL-ETHYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FMJA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 4-(5-METHYL-3-PHENYL-ISOXAZOL-4-YL)-PYRIMIDIN-2-YLAMINE
3FMKA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-8-METHYL-2-((S)-1-METHYL-2-TETRAZOL-2-YL-ETHYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FMLA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6224
3FMMA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6226
3FMNA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO2530
3FSFA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 3-(2,6-DICHLORO-PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-3,4-DIHYDRO-1H-PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE
3FSKA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6257
3GCPA:HUMAN P38 MAP KINASE IN COMPLEX WITH SB203580
3GCQA:HUMAN P38 MAP KINASE IN COMPLEX WITH RL45
3GCSA:HUMAN P38 MAP KINASE IN COMPLEX WITH SORAFENIB
3GCUA:; B:HUMAN P38 MAP KINASE IN COMPLEX WITH RL48
3GCVA:HUMAN P38 MAP KINASE IN COMPLEX WITH RL62
3GFEA:CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A PYRAZOLOPYRIDINONE INHIBITOR
3GI3A:CRYSTAL STRUCTURE OF A N-PHENYL-N'-NAPHTHYLUREA ANALOG IN COMPLEX WITH P38 MAP KINASE
3HA8A:THE COMPLEX STRUCTURE OF THE MAP KINASE P38/COMPOUND 14B
3HECA:P38 IN COMPLEX WITH IMATINIB
3HEGA:P38 IN COMPLEX WITH SORAFENIB
3HRBA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3HUBA:HUMAN P38 MAP KINASE IN COMPLEX WITH SCIOS-469
3HUCA:HUMAN P38 MAP KINASE IN COMPLEX WITH RL40
3HV3A:HUMAN P38 MAP KINASE IN COMPLEX WITH RL49
3HV4A:; B:HUMAN P38 MAP KINASE IN COMPLEX WITH RL51
3HV5A:; B:HUMAN P38 MAP KINASE IN COMPLEX WITH RL24
3HV6A:HUMAN P38 MAP KINASE IN COMPLEX WITH RL39
3HV7A:HUMAN P38 MAP KINASE IN COMPLEX WITH RL38
3HVCA:CRYSTAL STRUCTURE OF HUMAN P38ALPHA MAP KINASE
3IPHA:CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH A BIPHENYLAMIDE INHIBITOR
3ITZA:CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3IW5A:HUMAN P38 MAP KINASE IN COMPLEX WITH AN INDOLE DERIVATIVE
3IW6A:HUMAN P38 MAP KINASE IN COMPLEX WITH A BENZYLPIPERAZIN-PYRROL
3IW7A:HUMAN P38 MAP KINASE IN COMPLEX WITH AN IMIDAZO-PYRIDINE
3IW8A:STRUCTURE OF INACTIVE HUMAN P38 MAP KINASE IN COMPLEX WITH A THIAZOLE-UREA
3K3IA:P38ALPHA BOUND TO NOVEL DGF-OUT COMPOUND PF-00215955
3K3JA:P38ALPHA BOUND TO NOVEL DFG-OUT COMPOUND PF-00416121
3KQ7A:STRUCTURE OF HUMAN P38ALPHA WITH N-[4-METHYL-3-(6-{[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]AMINO}PYRIDINE-3-AMIDO)PHENYL]-2-(MORPHOLIN-4-YL)PYRIDINE-4-CARBOXAMIDE
3L8SA:HUMAN P38 MAP KINASE IN COMPLEX WITH CP-547632
3L8XA:P38 ALPHA KINASE COMPLEXED WITH A PYRAZOLO-PYRIMIDINE BASED INHIBITOR
3LFAA:HUMAN P38 MAP KINASE IN COMPLEX WITH DASATINIB
3LFBA:HUMAN P38 MAP KINASE IN COMPLEX WITH RL98
3LFCA:HUMAN P38 MAP KINASE IN COMPLEX WITH RL99
3LFEA:HUMAN P38 MAP KINASE IN COMPLEX WITH RL116
3LFFA:HUMAN P38 MAP KINASE IN COMPLEX WITH RL166
3MGYA:MUTAGENESIS OF P38 MAP KINASE ESHTABLISHES KEY ROLES OF PHE169 IN FUNCTION AND STRUCTURAL DYNAMICS AND REVEALS A NOVEL DFG-OUT STATE
3MH0A:MUTAGENESIS OF P38 MAP KINASE ESHTABLISHES KEY ROLES OF PHE169 IN FUNCTION AND STRUCTURAL DYNAMICS AND REVEALS A NOVEL DFG-OUT STATE
3MH1A:MUTAGENESIS OF P38 MAP KINASE ESTABLISHES KEY ROLES OF PHE169 IN FUNCTION AND STRUCTURAL DYNAMICS AND REVEALS A NOVEL DFG-OUT STATE
3MH2A:MUTAGENESIS OF P38 MAP KINASE ESTABLISHES KEY ROLES OF PHE169 IN FUNCTION AND STRUCTURAL DYNAMICS AND REVEALS A NOVEL DFG-OUT STATE
3MH3A:MUTAGENESIS OF P38 MAP KINASE ESTABLISHES KEY ROLES OF PHE169 IN FUNCTION AND STRUCTURAL DYNAMICS AND REVEALS A NOVEL DFG-OUT STATE
3MPAA:CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MOTIF MUTANTS IN RESPONSE TO INHIBITOR BINDING
3MPTA:CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A PYRROLE-2-CARBOXAMIDE INHIBITOR
3MVLA:; B:P38 ALPHA MAP KINASE COMPLEXED WITH PYRROLOTRIAZINE INHIBITOR 7K
3MVMA:; B:P38 ALPHA MAP KINASE COMPLEXED WITH PYRROLOTRIAZINE INHIBITOR 7V
3MW1A:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3NEWA:P38-ALPHA COMPLEXED WITH COMPOUND 10
3NNUA:CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH DP1376
3NNVA:CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH DP437
3NNWA:CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH DP802
3NNXA:CRYSTAL STRUCTURE OF PHOSPHORYLATED P38 ALPHA IN COMPLEX WITH DP802
3NWWA:P38 ALPHA KINASE COMPLEXED WITH A 2-AMINOTHIAZOL-5-YL-PYRIMIDINE BASED INHIBITOR
3O8PA:CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MOTIF MUTANTS IN RESPONSE TO INHIBITOR BINDING
3O8TA:CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG-MOTIF MUTANTS IN RESPONSE TO INHIBITOR BINDING
3O8UA:CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MOTIF MUTANTS IN RESPONSE TO INHIBITOR BINDING
3OBGA:CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MUTANTS IN RESPONSE TO INHIBITOR BINDING
3OBJA:CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MUTANTS IN RESPONSE TO INHIBITOR BINDING
3OC1A:CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MOTIF MUTANTS IN RESPONSE TO INHIBITOR BINDING
3OCGA:P38 ALPHA KINASE COMPLEXED WITH A 5-AMINO-PYRAZOLE BASED INHIBITOR
3OD6X:CRYSTAL STRUCTURE OF P38ALPHA Y323T ACTIVE MUTANT
3ODYX:CRYSTAL STRUCTURE OF P38ALPHA Y323Q ACTIVE MUTANT
3ODZX:CRYSTAL STRUCTURE OF P38ALPHA Y323R ACTIVE MUTANT
3OEFX:CRYSTAL STRUCTURE OF Y323F INACTIVE MUTANT OF P38ALPHA MAP KINASE
3PG3A:HUMAN P38 MAP KINASE IN COMPLEX WITH RL182
3QUDA:HUMAN P38 MAP KINASE IN COMPLEX WITH 2-AMINO-PHENYLAMINO-BENZOPHENONE
3QUEA:HUMAN P38 MAP KINASE IN COMPLEX WITH SKEPINONE-L
3RINA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3S3IA:P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3S4QA:P38 ALPHA KINASE COMPLEXED WITH A PYRAZOLO-TRIAZINE BASED INHIBITOR
3U8WA:CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A TRIAZOLOPYRIDAZINONE INHIBITOR
3UVPA:HUMAN P38 MAP KINASE IN COMPLEX WITH A BENZAMIDE SUBSTITUTED BENZOSUBERONE
3UVQA:HUMAN P38 MAP KINASE IN COMPLEX WITH A DIBENZOSUBERONE DERIVATIVE
3UVRA:HUMAN P38 MAP KINASE IN COMPLEX WITH KM064
4A9YA:P38ALPHA MAP KINASE BOUND TO CMPD 8
4AA4A:P38ALPHA MAP KINASE BOUND TO CMPD 22
4AA5A:P38ALPHA MAP KINASE BOUND TO CMPD 33
4AACA:P38ALPHA MAP KINASE BOUND TO CMPD 29
4DLIA:HUMAN P38 MAP KINASE IN COMPLEX WITH RL87
4DLJA:HUMAN P38 MAP KINASE IN COMPLEX WITH RL163
4E5AX:THE W197A MUTANT OF P38A MAP KINASE
4E5BA:STRUCTURE OF P38A MAP KINASE WITHOUT BOG
4E6AA:P38A-PIA23 COMPLEX
4E6CA:P38A-PERIFOSINE COMPLEX
4E8AA:THE CRYSTAL STRUCTURE OF P38A MAP KINASE IN COMPLEX WITH PIA24
4EH2A:HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F1 AND RL87
4EH3A:HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F2 AND RL87
4EH4A:HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F3 AND RL87
4EH5A:HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F4 AND RL87
4EH6A:HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F5 AND RL87
4EH7A:HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F6 AND RL87
4EH8A:HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F7 AND RL87
4EH9A:HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F11 AND RL87
4EHVA:HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F10 AND RL87
4EWQA:HUMAN P38 ALPHA MAPK IN COMPLEX WITH A PYRIDAZINE BASED INHIBITOR
4F9WA:HUMAN P38ALPHA MAPK IN COMPLEX WITH A NOVEL AND SELECTIVE SMALL MOLECULE INHIBITOR
4F9YA:HUMAN P38 ALPHA MAPK IN COMPLEX WITH A NOVEL AND SELECTIVE SMALL MOLECULE INHIBITOR
4FA2A:HUMAN P38 ALPHA MITOGEN-ACTIVATED KINASE IN COMPLEX WITH SB239063
4GEOA:P38A MAP KINASE DEF-POCKET PENTA MUTANT (M194A, L195A, H228A, I229A, Y258A)
4KINA:; B:; C:; D:CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE 14 (P38-H5) COMPLEX WITH 5-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-2-THIOPHENECARBOXAMIDE
4KIPA:; B:CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE 14 (P38-H5) COMPLEX WITH 2-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-1,3-THIAZOLE-5-CARBOXAMIDE
4KIQA:; B:; C:; D:CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE 14 (P38-H5) COMPLEX WITH ETHYL 6-((5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL) CARBAMOYL)-1H-INDOLE-1-CARBOXYLATE
4L8MA:HUMAN P38 MAP KINASE IN COMPLEX WITH A DIBENZOXEPINONE
(-)
Mouse (Mus musculus) [TaxId: 10090] (22)
1LEWA:CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A
1LEZA:CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS ACTIVATOR MKK3B
1P38  [entry was replaced by entry 5UOJ without any SCOP domain information]
1YW2A:MUTATED MUS MUSCULUS P38 KINASE (MP38)
1YWRA:CRYSTAL STRUCTURE ANALYSIS OF INACTIVE P38 KINASE DOMAIN IN COMPLEX WITH A MONOCYCLIC PYRAZOLONE INHIBITOR
2EWAA:DUAL BINDING MODE OF PYRIDINYLIMIDAZOLE TO MAP KINASE P38
2GHLA:MUTANT MUS MUSCULUS P38 KINASE DOMAIN IN COMPLEX WITH INHIBITOR PG-874743
2GHMA:MUTATED MAP KINASE P38 (MUS MUSCULUS) IN COMPLEX WITH INHBITOR PG-895449
2GTMA:MUTATED MOUSE P38 MAP KINASE DOMAIN IN COMPLEX WITH INHIBITOR PG-892579
2GTNA:MUTATED MAP KINASE P38 (MUS MUSCULUS) IN COMPLEX WITH INHBITOR PG-951717
2OZAB:STRUCTURE OF P38ALPHA COMPLEX
2PUUA:CRYSTAL STRUCTURE OF P38 COMPLEX WITH 1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(6-MORPHOLIN-4-YLMETHYL-PYRIDIN-3-YL)NAPHTHALEN-1-YL]UREA
3P4KA:THE THIRD CONFORMATION OF P38A MAP KINASE OBSERVED IN PHOSPHORYLATED P38A AND IN SOLUTION
3P5KA:P38 INHIBITOR-BOUND
3P78A:P38 INHIBITOR-BOUND
3P79A:P38 INHIBITOR-BOUND
3P7AA:P38 INHIBITOR-BOUND
3P7BA:P38 INHIBITOR-BOUND
3P7CA:P38 INHIBITOR-BOUND
3PY3A:CRYSTAL STRUCTURE OF PHOSPHORYLATED P38ALPHA MAP KINASE
3TG1A:CRYSTAL STRUCTURE OF P38ALPHA IN COMPLEX WITH A MAPK DOCKING PARTNER
4KA3A:STRUCTURE OF MAP KINASE IN COMPLEX WITH A DOCKING PEPTIDE
(-)
Protein domain: MAP kinase p38-gamma (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1CM8A:; B:PHOSPHORYLATED MAP KINASE P38-GAMMA
(-)
Protein domain: Mitogen-activated protein kinase 8 (jnk1) (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1UKHA:STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125
1UKIA:STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125
(-)
Protein domain: Musk tyrosine kinase (1)
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (1)
1LUFA:CRYSTAL STRUCTURE OF THE MUSK TYROSINE KINASE: INSIGHTS INTO RECEPTOR AUTOREGULATION
(-)
Protein domain: Mycobacterial protein kinase PknB, catalytic domain (3)
(-)
Mycobacterium tuberculosis [TaxId: 1773] (3)
1MRUA:; B:INTRACELLULAR SER/THR PROTEIN KINASE DOMAIN OF MYCOBACTERIUM TUBERCULOSIS PKNB.
1O6YA:CATALYTIC DOMAIN OF PKNB KINASE FROM MYCOBACTERIUM TUBERCULOSIS
2FUMA:; B:; C:; D:CATALYTIC DOMAIN OF PROTEIN KINASE PKNB FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MITOXANTRONE
(-)
Protein domain: pak1 (11)
(-)
Human (Homo sapiens) [TaxId: 9606] (11)
1F3MC:; D:CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1
1YHVA:CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH TWO POINT MUTATIONS (K299R, T423E)
1YHWA:CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH ONE POINT MUTATIONS (K299R)
2HY81:PAK1 COMPLEX WITH ST2001
3FXZA:CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH RUTHENIUM COMPLEX LAMBDA-FL172
3FY0A:CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH RUTHENIUM COMPLEX DW1
3Q4ZA:; B:STRUCTURE OF UNPHOSPHORYLATED PAK1 KINASE DOMAIN
3Q52A:STRUCTURE OF PHOSPHORYLATED PAK1 KINASE DOMAIN
3Q53A:STRUCTURE OF PHOSPHORYLATED PAK1 KINASE DOMAIN IN COMPLEX WITH ATP
4DAWA:CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH THE RUTHENIUM PHTHALIMIDE COMPLEX
4EQCA:CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN IN COMPLEX WITH FRAX597 INHIBITOR
(-)
Protein domain: Pkb kinase (Akt-2) (16)
(-)
Human (Homo sapiens) [TaxId: 9606] (16)
1GZKA:MOLECULAR MECHANISM FOR THE REGULATION OF PROTEIN KINASE B/ AKT BY HYDROPHOBIC MOTIF PHOSPHORYLATION
1GZNA:STRUCTURE OF PKB KINASE DOMAIN
1GZOA:STRUCTURE OF PROTEIN KINASE B UNPHOSPHORYLATED
1MRVA:CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN
1MRYA:CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN
1O6KA:STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 PEPTIDE AND AMP-PNP
1O6LA:CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE
2JDOA:STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE
2JDRA:STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654
2UW9A:STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE
2X39A:STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D) PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE BOUND TO PKB
2XH5A:STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2,3-D) PYRIMIDIN-4-YL)PIPERIDIN-4-AMINE BOUND TO PKB
3D0EA:; B:CRYSTAL STRUCTURE OF HUMAN AKT2 IN COMPLEX WITH GSK690693
3E87A:; B:CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
3E88A:; B:CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
3E8DA:; B:CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
(-)
Protein domain: Protein kinase C, theta type (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1XJDA:CRYSTAL STRUCTURE OF PKC-THETA COMPLEXED WITH STAUROSPORINE AT 2A RESOLUTION
(-)
Protein domain: Protein kinase CK2, alpha subunit (68)
(-)
Human (Homo sapiens) [TaxId: 9606] (36)
1JWHA:; B:CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME
1NA7A:CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2
1PJKA:CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
2PVRA:CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 (C-TERMINAL DELETION MUTANT 1-335) IN COMPLEX WITH TWO SULFATE IONS
3AT2A:CRYSTAL STRUCTURE OF CK2ALPHA
3AT3A:CRYSTAL STRUCTURE OF CK2ALPHA WITH PYRADINE DERIVATIVE
3AT4A:CRYSTAL STRUCTURE OF CK2ALPHA WITH PYRADINE DERIVERTIVE
3BQCA:HIGH PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3C13A:LOW PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3H30A:; B:CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 WITH 5,6-DICHLORO-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE
3JUHA:; B:CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY
3MB6A:HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A DIFURANE DERIVATIVE INHIBITOR (CPA)
3MB7A:HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A DIFURANE DERIVATIVE INHIBITOR (AMR)
3NSZA:HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH AMPPN
3OWJA:HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A PYRIDOCARBAZOLE DERIVATIVE INHIBITOR
3OWKA:HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A BENZOPYRIDOINDOLE DERIVATIVE INHIBITOR
3OWLA:HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH A BENZOPYRIDOINDOLE DERIVATIVE INHIBITOR
3PE1A:CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR CX-4945
3PE2A:CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 IN COMPLEX WITH THE INHIBITOR CX-5011
3Q04A:CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 8.5
3Q9WA:CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 8.5
3Q9XA:; B:CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH EMODIN AT PH 6.5
3Q9YA:CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 8.5
3Q9ZA:; B:CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA IN COMPLEX WITH QUINALIZARIN AT PH 6.5
3QA0A:; B:CRYSTAL STRUCTURE OF THE APO-FORM OF HUMAN CK2 ALPHA AT PH 6.5
3R0TA:CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR CX-5279
3RPSA:; B:STRUCTURE OF HUMAN CK2ALPHA IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 3-(4,5,6,7-TETRABROMO-1H-BENZOTRIAZOL-1-YL)PROPAN-1-OL
3U4UA:CASEIN KINASE 2 IN COMPLEX WITH AZ-INHIBITOR
3U87A:; B:STRUCTURE OF A CHIMERIC CONSTRUCT OF HUMAN CK2ALPHA AND HUMAN CK2ALPHA' IN COMPLEX WITH A NON-HYDROLYSABLE ATP-ANALOGUE
3W8LA:; B:CRYSTAL STRUCTURE OF HUMAN CK2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE
3WARA:CRYSTAL STRUCTURE OF HUMAN CK2A
4DGLC:; D:CRYSTAL STRUCTURE OF THE CK2 TETRAMERIC HOLOENZYME
4FBXA:COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT CRYSTALLIZED IN THE PRESENCE OF A BISUBSTRATE INHIBITOR
4GRBA:CASEIN KINASE 2 (CK2) BOUND TO INHIBITOR
4KWPA:CRYSTAL STRUCTURE OF HUMAN CK2-ALPHA IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR (K164) AT 1.25 A RESOLUTION
4MD7E:; F:; G:; H:CRYSTAL STRUCTURE OF FULL-LENGTH SYMMETRIC CK2 HOLOENZYME
(-)
Maize (Zea mays) [TaxId: 4577] (31)
1DAWA:CRYSTAL STRUCTURE OF A BINARY COMPLEX OF PROTEIN KINASE CK2 (ALPHA-SUBUNIT) AND MG-AMPPNP
1DAYA:CRYSTAL STRUCTURE OF A BINARY COMPLEX OF PROTEIN KINASE CK2 (ALPHA-SUBUNIT) AND MG-GMPPNP
1DS5A:; B:; C:; D:DIMERIC CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT IN COMPLEX WITH TWO BETA PEPTIDES MIMICKING THE ARCHITECTURE OF THE TETRAMERIC PROTEIN KINASE CK2 HOLOENZYME.
1F0QA:CRYSTAL STRUCTURE OF THE ALPHA SUBUNIT OF PROTEIN KINASE CK2 IN COMPLEX WITH THE NUCLEOTIDE COMPETITIVE INHIBITOR EMODIN
1J91A:; B:CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE
1JAMA:CRYSTAL STRUCTURE OF APO-FORM OF Z. MAYS CK2 PROTEIN KINASE ALPHA SUBUNIT
1LP4A:CRYSTAL STRUCTURE OF A BINARY COMPLEX OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 WITH MG-AMPPNP
1LPUA:LOW TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS
1LR4A:ROOM TEMPERATURE CRYSTAL STRUCTURE OF THE APO-FORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM ZEA MAYS
1M2PA:CRYSTAL STRUCTURE OF 1,8-DI-HYDROXY-4-NITRO-ANTHRAQUINONE/CK2 KINASE COMPLEX
1M2QA:CRYSTAL STRUCTURE OF 1,8-DI-HYDROXY-4-NITRO-XANTEN-9-ONE/CK2 KINASE COMPLEX
1M2RA:CRYSTAL STRUCTURE OF 5,8-DI-AMINO-1,4-DI-HYDROXY-ANTHRAQUINONE/CK2 KINASE COMPLEX
1OM1A:CRYSTAL STRUCTURE OF MAIZE CK2 ALPHA IN COMPLEX WITH IQA
1ZOEA:CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB-DERIVATIVES INHIBITORS
1ZOGA:CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB-DERIVATIVES
1ZOHA:CRYSTAL STRUCTURE OF PROTEIN KINASE CK2 IN COMPLEX WITH TBB-DERIVATIVES INHIBITORS
2OXDA:PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE K17, K22 AND K32 INHIBITORS
2OXXA:PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17, K22 AND K32
2OXYA:; B:PROTEIN KINASE CK2 IN COMPLEX WITH TETRABROMOBENZOIMIDAZOLE DERIVATIVES K17, K22 AND K32
2QC6A:PROTEIN KINASE CK2 IN COMPLEX WITH DBC
3FL5A:PROTEIN KINASE CK2 IN COMPLEX WITH THE INHIBITOR QUINALIZARIN
3KXGA:CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR 3,4,5,6,7-PENTABROMO-1H-INDAZOLE (K64)
3KXHA:CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR (2-DYMETHYLAMMINO-4,5,6,7-TETRABROMOBENZOIMIDAZOL-1YL-ACETIC ACID (K66)
3KXMA:CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR K74
3KXNA:CRYSTAL STRUCTURE OF Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR TETRAIODOBENZIMIDAZOLE (K88)
3PVGA:CRYSTAL STRUCTURE OF Z. MAYS CK2 ALPHA SUBUNIT IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMO-1-CARBOXYMETHYLBENZIMIDAZOLE (K68)
3PWDA:CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH NBC (Z1)
3PZHA:CRYSTAL STRUCTURE OF MAIZE CK2 ALPHA IN COMPLEX WITH EMODIN AT 1.92 A RESOLUTION
4DGMA:CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH THE INHIBITOR APIGENIN
4DGNA:CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH THE INHIBITOR LUTEOLIN
4DGOA:CRYSTAL STRUCTURE OF MAIZE CK2 IN COMPLEX WITH TYRPHOSTIN AG99
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (1)
2R7IA:; B:; C:; D:CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
(-)
Protein domain: Protein kinase wnk1 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
3FPQA:; B:CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF WNK1
(-)
Protein domain: Proto-oncogene serine/threonine-protein kinase Pim-1 (64)
(-)
Human (Homo sapiens) [TaxId: 9606] (64)
1XQZA:CRYSTAL STRUCTURE OF HPIM-1 KINASE AT 2.1 A RESOLUTION
1XR1A:CRYSTAL STRUCTURE OF HPIM-1 KINASE IN COMPLEX WITH AMP-PNP AT 2.1 A RESOLUTION
1XWSA:CRYSTAL STRUCTURE OF THE HUMAN PIM1 KINASE DOMAIN
1YHSA:CRYSTAL STRUCTURE OF PIM-1 BOUND TO STAUROSPORINE
1YI3A:CRYSTAL STRUCTURE OF PIM-1 BOUND TO LY294002
1YI4A:STRUCTURE OF PIM-1 BOUND TO ADENOSINE
1YWVA:CRYSTAL STRUCTURES OF PROTO-ONCOGENE KINASE PIM1: A TARGET OF ABERRANT SOMATIC HYPERMUTATIONS IN DIFFUSE LARGE CELL LYMPHOMA
1YXSA:CRYSTAL STRUCTURE OF KINASE PIM1 WITH P123M MUTATION
1YXTA:CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMPPNP
1YXUA:; B:; C:; D:CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
1YXVA:CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH 3,4-DIHYDROXY-1-METHYLQUINOLIN-2(1H)-ONE
1YXXA:CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH (3E)-3-[(4-HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE
2O3PA:CRYSTAL STRUCTURE OF PIM1 WITH QUERCETIN
2O63A:CRYSTAL STRUCTURE OF PIM1 WITH MYRICETIN
2O64A:CRYSTAL STRUCTURE OF PIM1 WITH QUERCETAGETIN
2O65A:CRYSTAL STRUCTURE OF PIM1 WITH PENTAHYDROXYFLAVONE
2OI4X:CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH FLUORINATED RUTHENIUM PYRIDOCARBAZOLE
2XJ2A:PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3A99A:STRUCTURE OF PIM-1 KINASE CRYSTALLIZED IN THE PRESENCE OF P27KIP1 CARBOXY-TERMINAL PEPTIDE
3BGPA:HUMAN PIM-1 COMPLEXED WITH A BENZOISOXAZOLE INHIBITOR VX1
3BGQA:HUMAN PIM-1 KINASE IN COMPLEX WITH AN TRIAZOLO PYRIDAZINE INHIBITOR VX2
3BGZA:HUMAN PIM-1 KINASE IN COMPLEX WITH DIPHENYL INDOLE INHIBITOR VX3
3BWFA:CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AN OSMIUM COMPOUND
3C4EA:; B:; C:; D:PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7-AZAINDOLE
3DCVA:CRYSTAL STRUCTURE OF HUMAN PIM1 KINASE COMPLEXED WITH 4-(4-HYDROXY-3-METHYL-PHENYL)-6-PHENYLPYRIMIDIN-2(1H)-ONE
3F2AA:CRYSTAL STRUCTURE OF HUMAN PIM-1 IN COMPLEX WITH DAPPA
3JPVA:CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A PYRROLO[2,3-A]CARBAZOLE LIGAND
3JXWA:DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3JY0A:DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3JYAA:DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3MA3A:CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A NAPHTHO-DIFURAN LIGAND
3R00A:THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
3R01A:THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
3R02A:THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
3R04A:THE DISCOVERY OF NOVEL BENZOFURAN-2-CARBOXYLIC ACIDS AS POTENT PIM-1 INHIBITORS
3T9IA:PIM1 COMPLEXED WITH A NOVEL 3,6-DISUBSTITUTED INDOLE AT 2.6 ANG RESOLUTION
3UIXA:CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3UMWA:CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH INHIBITOR (Z)-2-[(1H-INDAZOL-3-YL)METHYLENE]-6-METHOXY-7-(PIPERAZIN-1-YLMETHYL)BENZOFURAN-3(2H)-ONE
3UMXA:CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH INHIBITOR (Z)-2-[(1H-INDOL-3-YL)METHYLENE]-7-(AZEPAN-1-YLMETHYL)-6-HYDROXYBENZOFURAN-3(2H)-ONE
3VBQA:EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
3VBTA:EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
3VBVA:EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
3VBWA:EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
3VBXA:EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
3VBYA:EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
3VC4A:EXPLOITATION OF HYDROGEN BONDING CONSTRAINTS AND FLAT HYDROPHOBIC ENERGY LANDSCAPES IN PIM-1 KINASE NEEDLE SCREENING AND INHIBITOR DESIGN
4DTKA:NOVEL AND SELECTIVE PAN-PIM KINASE INHIBITOR
4ENXA:CRYSTAL STRUCTURE OF PIM-1 KINASE IN COMPLEX WITH INHIBITOR (2E,5Z)-2-(2-CHLOROPHENYLIMINO)-5-(4-HYDROXY-3-NITROBENZYLIDENE)THIAZOLIDIN-4-ONE
4ENYA:CRYSTAL STRUCTURE OF PIM-1 KINASE IN COMPLEX WITH (2E,5Z)-2-(2-CHLOROPHENYLIMINO)-5-(4-HYDROXY-3-METHOXYBENZYLIDENE)THIAZOLIDIN-4-ONE
4IAAA:CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH THIORIDAZINE
4JX3A:CRYSTAL STRUCTURE OF PIM1 KINASE
4JX7A:CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH INHIBITOR 2-[(TRANS-4-AMINOCYCLOHEXYL)AMINO]-4-{[3-(TRIFLUOROMETHYL) PHENYL]AMINO}PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE
4K0YA:STRUCTURE OF PIM-1 KINASE BOUND TO N-(4-FLUOROPHENYL)-7-HYDROXY-5-(PIPERIDIN-4-YL)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE
4K18A:STRUCTURE OF PIM-1 KINASE BOUND TO 5-(4-CYANOBENZYL)-N-(4-FLUOROPHENYL)-7-HYDROXYPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE
4K1BA:STRUCTURE OF PIM-1 KINASE BOUND TO N-(5-(2-FLUOROPHENYL)-1H-PYRROLO[2, 3-B]PYRIDIN-3-YL)-5-((((3R,4R)-3-FLUOROPIPERIDIN-4-YL)METHYL)AMINO) PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE
4LL5A:CRYSTAL STRUCTURE OF PIM-1 IN COMPLEX WITH THE FLUORESCENT COMPOUND SKF86002
4LM5A:CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH 2-{4-[(3-AMINOPROPYL) AMINO]QUINAZOLIN-2-YL}PHENOL (RESULTING FROM DISPLACEMENT OF SKF86002)
4LMUA:CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH THE INHIBITOR QUERCETIN (RESULTING FROM DISPLACEMENT OF SKF86002)
4MBIA:DISCOVERY OF PYRAZOLO[1,5A]PYRIMIDINE-BASED PIM1 INHIBITORS
4MBLA:DISCOVERY OF PYRAZOLO[1,5A]PYRIMIDINE-BASED PIM1 INHIBITORS
4MEDA:CRYSTAL STRUCTURE OF SER/THR KINASE PIM1 IN COMPLEX WITH THIORIDAZINE DERIVATIVES
4N6YA:PIM1 COMPLEXED WITH A PHENYLCARBOXAMIDE
4N6ZA:PIM1 COMPLEXED WITH A PYRIDYLCARBOXAMIDE
4N70A:PIM1 COMPLEXED WITH A PYRIDYLCARBOXAMIDE
(-)
Protein domain: Ribosomal protein S6 kinase alpha 5, Msk1 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1VZOA:THE STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF MSK1 REVEALS A NOVEL AUTOINHIBITORY CONFORMATION FOR A DUAL KINASE PROTEIN
(-)
Protein domain: Serine/threonine protein kinase TAO2 (3)
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (3)
1U5QA:; B:CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
1U5RA:; B:CRYSTAL STRUCTURE OF THE TAO2 KINASE DOMAIN: ACTIVATION AND SPECIFITY OF A STE20P MAP3K
2GCDA:; B:TAO2 KINASE DOMAIN-STAUROSPORINE STRUCTURE
(-)
Protein domain: Serine/threonine-protein kinase Nek2 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
2JAVA:3-271HUMAN KINASE WITH PYRROLE-INDOLINONE LIGAND
(-)
Protein domain: Sky1p (5)
(-)
Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932] (5)
1HOWA:THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST
1Q8YA:; B:THE STRUCTURE OF THE YEAST SR PROTEIN KINASE, SKY1P, WITH BOUND ADP
1Q8ZA:; B:THE APOENZYME STRUCTURE OF THE YEAST SR PROTEIN KINASE, SKY1P
1Q97A:; B:THE STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINASE, SKY1P, WITH BOUND ATP
1Q99A:; B:CRYSTAL STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SR PROTEIN KINSAE, SKY1P, COMPLEXED WITH THE NON-HYDROLYZABLE ATP ANALOGUE, AMP-PNP
(-)
Protein domain: STE20-like serine/threonine-protein kinase, SLK (4)
(-)
Human (Homo sapiens) [TaxId: 9606] (4)
2J51A:CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE BOUND TO 5-AMINO-3-((4-(AMINOSULFONYL)PHENYL)AMINO)-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
2JFLA:CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE ( DIPHOSPHORYLATED FORM) BOUND TO 5- AMINO-3-((4-( AMINOSULFONYL)PHENYL)AMINO)-N-(2,6- DIFLUOROPHENYL)-1H-1,2, 4-TRIAZOLE-1-CARBOTHIOAMIDE
2JFMA:CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE (UNLIGANDED FORM)
2UV2A:21-308CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE BOUND TO 4-(4-( 5-CYCLOPROPYL-1H-PYRAZOL-3-YLAMINO)-QUINAZOLIN-2-YLAMINO)-PHENYL)-ACETONITRILE
(-)
Protein domain: Tie2 kinase (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1FVRA:; B:TIE2 KINASE DOMAIN
(-)
Protein domain: Titin, kinase domain (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1TKIA:; B:AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN
(-)
Protein domain: Twitchin, kinase domain (2)
(-)
Caenorhabditis elegans, pjk4 [TaxId: 6239] (1)
1KOAA:5915-6264TWITCHIN KINASE FRAGMENT (C.ELEGANS), AUTOREGULATED PROTEIN KINASE AND IMMUNOGLOBULIN DOMAINS
(-)
California sea hare (Aplysia californica), twk43 [TaxId: 6500] (1)
1KOBA:; B:TWITCHIN KINASE FRAGMENT (APLYSIA), AUTOREGULATED PROTEIN KINASE DOMAIN
(-)
Protein domain: Type I TGF-beta receptor R4 (10)
(-)
Human (Homo sapiens) [TaxId: 9606] (10)
1B6CB:; F:; H:; D:CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
1IASA:; B:; C:; D:; E:CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
1PY5A:CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH INHIBITOR
1RW8A:CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH ATP SITE INHIBITOR
1VJYA:CRYSTAL STRUCTURE OF A NAPHTHYRIDINE INHIBITOR OF HUMAN TGF-BETA TYPE I RECEPTOR
2WOTA:ALK5 IN COMPLEX WITH 4-((5,6-DIMETHYL-2-(2-PYRIDYL)-3-PYRIDYL)OXY)-N-(3,4,5-TRIMETHOXYPHENYL)PYRIDIN-2-AMINE
2WOUA:ALK5 IN COMPLEX WITH 4-((4-((2,6-DIMETHYL-3-PYRIDYL)OXY)-2-PYRIDYL)AMINO)BENZENESULFONAMIDE
3GXLA:ALK-5 KINASE COMPLEX WITH GW857175
3HMMA:STRUCTURE OF ALK5 + GW855857
3TZMA:TGF-BETA RECEPTOR TYPE 1 IN COMPLEX WITH SB431542
(-)
Protein domain: Tyrosine-protein kinase Itk/Tsk (26)
(-)
Human (Homo sapiens) [TaxId: 9606] (26)
1SM2A:; B:CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1SNUA:; B:CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1SNXA:; B:CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
3MIYA:; B:X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH SUNITINIB
3MJ1A:X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR RO5191614
3MJ2A:X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR BMS-509744
3QGWA:; B:CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR
3QGYA:; B:CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX
3T9TA:CRYSTAL STRUCTURE OF BTK MUTANT (F435T,K596R) COMPLEXED WITH IMIDAZO[1,5-A]QUINOXALINE
3V5JA:; B:CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 090
3V5LA:; B:; C:; D:CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542
3V8TA:; B:CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 477
3V8WA:; B:CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE ITK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 469
4HCTA:CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 52
4HCUA:CRYSTAL STRUCTURE OF ITK IN COMPLEXT WITH COMPOUND 40
4HCVA:CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 53
4KIOA:; B:; C:; D:KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH A COVALENTLY-BINDING INHIBITOR
4L7SA:; B:KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH AN AMINOBENZOTHIAZOLE INHIBITOR
4M0YA:CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 1 [4-(CARBAMOYLAMINO)-1-(NAPHTHALEN-1-YL)-1H-PYRAZOLE-3-CARBOXAMIDE]
4M0ZA:CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 5 {4-(CARBAMOYLAMINO)-1-(7-METHOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3-CARBOXAMIDE}
4M12A:CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 7 [4-(CARBAMOYLAMINO)-1-(7-ETHOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3-CARBOXAMIDE]
4M13A:CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 8 [4-(CARBAMOYLAMINO)-1-(7-PROPOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3-CARBOXAMIDE]
4M14A:CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 9 [4-(CARBAMOYLAMINO)-1-[7-(PROPAN-2-YLOXY)NAPHTHALEN-1-YL]-1H-PYRAZOLE-3-CARBOXAMIDE]
4M15A:CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 9 [4-(CARBAMOYLAMINO)-1-[7-(PROPAN-2-YLOXY)NAPHTHALEN-1-YL]-1H-PYRAZOLE-3-CARBOXAMIDE] AND ADP
4MF0A:; B:ITK KINASE DOMAIN IN COMPLEX WITH BENZOTHIAZOLE INHIBITOR COMPOUND 12A (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(PYRIDIN-3-YL)-1,3-BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE (12A)
4MF1A:; B:ITK KINASE DOMAIN IN COMPLEX WITH BENZOTHIAZOLE INHIBITOR 12B (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H-PYRAZOL-4-YL)-1,3-BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE
(-)
Protein domain: Tyrosine-protein kinase SYK (25)
(-)
Human (Homo sapiens) [TaxId: 9606] (25)
1XBAA:CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN
1XBBA:CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH GLEEVEC
1XBCA:CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH STAUROSPORIN
3EMGA:DISCOVERY AND SAR OF NOVEL 4-THIAZOLYL-2-PHENYLAMINOPYRIMIDINES AS POTENT INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)
3FQEA:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH YM193306
3FQHA:; B:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A 2-SUBSTITUTED 7-AZAINDOLE
3FQSA:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH R406
3SRVA:; B:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITOR
3TUBA:CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-(5-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-3-((1R,2S)-2-PHENYLCYCLOPROPYL)UREA
3TUCA:CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-BENZYL-N-(5-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE
3TUDA:CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH N-(4-METHYL-3-(8-METHYL-7-OXO-2-(PHENYLAMINO)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-6-YL)PHENYL)-3-(TRIFLUOROMETHYL)BENZAMIDE
3VF8A:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC DOMAIN WITH PYRAZOLYLBENZIMIDAZOLE INHIBITOR 416
3VF9A:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 027
4DFLA:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A SULFONAMIDOPYRAZINE PIPERIDINE INHIBITOR
4DFNA:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH AN ADAMANTYLPYRAZINE INHIBITOR
4F4PA:SYK IN COMPLEX WITH LIGAND LASW836
4FL1A:STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTIVATION SWITCH
4FYNA:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 3-(8-{4-[ETHYL-(2-HYDROXY-ETHYL)-AMINO]-PHENYLAMINO}-IMIDAZO[1,2-A]PYRAZIN-5-YL)-PHENOL
4FYOA:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH N-{(S)-1-[7-(3,4-DIMETHOXY-PHENYLAMINO)-THIAZOLO[5,4-D]PYRIMIDIN-5-YL]-PYRROLIDIN-3-YL}-TEREPHTHALAMIC ACID
4FZ6A:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH [6-((S)-2-METHYL-PYRROLIDIN-1-YL)-PYRIDIN-2-YL]-(6-PHENYL-IMIDAZO[1,2-B]PYRIDAZIN-8-YL)-AMINE
4FZ7A:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 6-((1R,2S)-2-AMINO-CYCLOHEXYLAMINO)-4-(6-ETHYL-PYRIDIN-2-YLAMINO)-PYRIDAZINE-3-CARBOXYLIC ACID AMIDE
4GFGA:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH R9021
4I0RA:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 2-(3,4,5-TRIMETHOXY-PHENYL)-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ISOPROPYLAMIDE
4I0SA:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 2-(6-CHLORO-1-METHYL-1H-INDAZOL-3-YL)-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ISOPROPYLAMIDE
4I0TA:CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH 2-(5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRIDIN-1-YL)-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID TERT-BUTYLAMIDE
(-)
Protein domain: Tyrosine-protein kinase ZAP-70 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1U59A:CRYSTAL STRUCTURE OF THE ZAP-70 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
(-)
Protein domain: Vascular endothelial growth factor receptor 2 (kdr) (20)
(-)
Human (Homo sapiens) [TaxId: 9606] (20)
1VR2A:HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN
1YWNA:VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO-FURO[2,3-D]PYRIMIDINE
2OH4A:CRYSTAL STRUCTURE OF VEGFR2 WITH A BENZIMIDAZOLE-UREA INHIBITOR
2P2HA:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDINYL-TRIAZINE INHIBITOR
2P2IA:; B:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NICOTINAMIDE INHIBITOR
2QU5A:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR
2QU6A:; B:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
2RL5A:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A 2,3-DIHYDRO-1,4-BENZOXAZINE INHIBITOR
3B8QA:; B:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
3B8RA:; B:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
3BE2A:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZAMIDE INHIBITOR
3C7QA:STRUCTURE OF VEGFR2 KINASE DOMAIN IN COMPLEX WITH BIBF1120
3CJFA:CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 3,4,5-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE
3CJGA:CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 3,4,5-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE
3CP9A:; B:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
3CPBA:; B:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BISAMIDE INHIBITOR
3CPCA:; B:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
3DTWA:; B:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZISOXAZOLE INHIBITOR
3EFLA:; B:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH MOTESANIB
3EWHA:CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDYL-PYRIMIDINE BENZIMIDAZOLE INHIBITOR